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CHAPTER I 
INTRODUCTION 
1. Introduction 
1.l Rationale 
In most industrialized countries, age-standardized cardiovascular disease mortality rates have 
shown a decreasing trend since the mid seventies (I). However, cardiovascular diseases are 
still the most important cause of morbidity and mortality in these countries. About one-half 
of the cardiovascular disease mOliality results from coronary heart disease and about one-
quarter from cerebrovascular disease. The main underlying process in these diseases is 
aUterosclerosis. Symptomatic atherosclerotic cardiovascular disease is predominantly a disease 
of the adult population. However, there is increasing evidence to suggest that the 
atherosclerotic process begins in childhood. Enos et al. (2) showed that a majority of young 
soldiers autopsied during the Korean war had significant atherosclerotic lesions in their 
coronary arteries. Subsequently, Holman et al. (3) showed that lesions are present in the aorta 
of children. McNamara et al. (4) autopsied American soldiers killed in action in Vietnam and 
reported that 45% of them had atherosclerotic lesions, and as much as 5% had severe coronary 
atherosclerosis. These and more recent observations (5-10) from autopsy studies clearly 
showed the onset of atherosclerotic coronary ariery disease by young adulthood. Similarly, 
autopsy studies suggested the presence of potential precursors of atherosclerotic lesions such 
as fatty streaks and fibrous plaques, or raised lesions, in the coronary arteries as early as the 
second decade of life (3, 11-13). In a recent report from the Bogalusa Heart Study (15), 
extensive intimal surface involvement with fatty streaks of the aorta and the coronary arteries 
was found in young adults, aged 6 to 30 years. Fibrous plaques were found in both the aorta 
and the coronaries. In the coronary arieries higher correlations of fatty streaks with raised 
fibrous plaques lesions were found than in the aorta. Pariicularly in the coronary arieries, the 
fatty streak lesion is a likely precursor of fibrous plaques (15). The above-mentioned studies 
reporting on vessel lesions in children and young adults made use of autopsies for their 
assessment. Recently, standardized noninvasive techniques for examining the carotid arteries 
of children and young adults have been developed (16), which potentially extends the 
possibilities for research on vessel wall characteristics to a more general population of children 
and young adults. Ultrasonic examinations in children have indicated that differences in the 
elastic properties of carotid arteries in children and young adults are detectable and relate to 
various risk factors for atherosclerotic cardiovascular disease and also to parental heart disease 
(17). 
Cholesterol and cholesterol esters have since long been recognized to be a constituent of 
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atherosclerotic lesions (18-21). This has led to the assumption that plasma lipids, and more 
in particular plasma low density lipoprotein cholesterol, play an essential role in the process 
of atherosclerosis. In non-human primates, cholesterol feeding was shown to be a prerequisite 
for the development of major atherosclerosis (22,23), and later studies demonstrated that 
chronic diet induced hypercholesterolemia led to fatty streak formation (24,25) similar to the 
fatty streaks observed in humans. Epidemiologic and laboratory studies have identified several 
risk factors contributing to the high prevalence and incidence of atherosclerotic coronary 
artery disease in industrialized countries. Among these risk factors, hypertension, 
hypercholesterolemia and smoking were disclosed as conditions independently linked to 
atherosclerotic coronary artery disease. The positive relation of semm total cholesterol, as welt 
as the inverse association of one of its subfractions, high density lipoprotein cholesterol with 
atherosclerosis is now welt established. Similarly, in particular high levels of another 
subfraction, low density lipoprotein cholesterol are associated with coronary artery disease 
(26-32). In children and young adults, particularly males, aorta fatty streaks were found to be 
strongly related to antemortem levels of total cholesterol and low density lipoprotein-
cholesterol and coronary artery fatty streaks with levels of triglycerides and very low density 
lipoprotein-cholesterol as welt as with systolic and diastolic blood pressure (14). 
Apolipoproteins are the protein components of lipoproteins, which are involved in the 
stmcture, receptor binding and enzymatic metabolism of these lipoproteins. These 
apolipoproteins have been studied in patients with ischaemic heart disease (33,34) as welt as 
in their offspring (35), but their relative merit as risk factors for coronary artery disease stitt 
has to be elucidated. 
It is since 1979 that more attention has been drawn to the possible association botween 
atherosclerosis and triglyceride-rich lipoproteins that occur in plasma primarily in the 
postprandial or fed state. (36) However, hypotheses about such an association date back much 
earlier. Moreton (37) proposed in 1947 that it was because of investigating only casual lipid 
concentrations, and primarily in the postabsorptive (fasting) state, that the clue to the 
underlying etiology of atherosclerosis had been missed. Much later it was reported that the 
renmants of chylomicrons, the principal carriers of dietary (exogenous) cholesterol and fat, 
are atherogenic in human adults (36, 38), thus giving support to this theory. There is no 
insight yet into the role of triglyceride-rich lipoproteins in the young. The finding of a strong 
association between fatty streak involvement in the coronary arteries of young males and 
antemortem levels of triglyceride and very low density lipoprotein-cholesterol (14) may be 
an indication that triglyceride-rich lipoproteins do playa role. 
In view of the process of atherosclerosis beginning in young adulthood it is worthwhile to 
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study this process in relation to semm lipids, (apo)lipoproteins and postprandial lipid 
metabolism in children and young adults as a means of gaining insight into how these factors 
may have contributed to the occurrence of coronary atherosclerosis in their parents. 
Eventually, this may not only lead to a better understanding of the etiology and the 
determinants of atherosclerotic cardiovascular diseases, but also provide a means for the 
prevention of these diseases. 
These considerations form the rationale for investigating lipids, (apo)lipoproteins and lipid 
metabolism in the young in relation to disease in their parents, with emphasis on fat intake 
and postprandial changes in lipid profiles. In the studies presented in this thesis lipids, 
(apo)lipoproteins and postprandial lipids and lipoproteins were investigated in offspring of 
parents suffering from clinically manifest and angiographically proven coronary 
atherosclerosis. The natural history of lipids and lipoproteins was studied in children and 
young adults in relation to parental total serum cholesterol levels. 
1.2 Study objectives 
A general question that may be asked is whether and how efforts to prevent cardiovascular 
diseases should start with children and young adults. Prevention of a chronic disease such as 
cardiovascular disease implies knowledge about the relevant risk factors in the young and their 
role in the etiology of cardiovascular disease. The objectives of the studies presented in this 
thesis were to assess, within the realm of familial cardiovascular disease, the causal relations 
between coronary artery disease as measured in adults and (apo )lipoprotein levels as measured 
in their offspring as a means of studying their role in the occurrence of parental disease. A 
furUler objective was to evaluate if cardiovascular risk factor levels show aggregation in 
families over time by relating parental risk factor levels and offspring risk factor levels. The 
latter should provide evidence for the idea that high risk parents may have offspring with high 
risk factor levels, which is important in the concept of such risk factors being causally related 
to the life-long process ultimately leading to cardiovascular disease. Familial aggregation of 
risk factors over time is also an important premise for shldies relating offspring risk factor 
levels to parental disease. Thus, in view of the knowledge on both the etiology and ultimately 
the prevention of atherogenesis it is important to assess whether levels of plasma lipids and 
(apo)lipoproteins measured at a yomlg age are related to heart disease. Similarly, studying 
postprandial lipid metabolism may provide new insights into atherogenesis and shed light on 
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predictors of heart disease. 
1.3 Chapter outline 
Chapter 2 describes a patient-offspring study of postpraudial lipid metabolism aud vitamin 
A metabolism and their relation with coronary atherosclerosis. In chapter 3 a patient-offspring 
study is presented on the relation between lipids aud (apo)lipoproteins in young people aud 
coronary artery disease in their parents. Chapter 4 presents the natural history of serum total 
cholesterol and lipoprotein-cholesterol levels in a follow-up study of young people in relation 
to total cholesterol levels in their parents. General discussion I in chapter 5 focuses on specific 
design aspects aud the interpretation of the patient-offspring study. General discussion II in 
chapter 6 places the findings of the studies as presented in this thesis in the context of the 
considerations in general discussion I. 
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Appendix 
In this thesis the emphasis is on lipids, (apo)lipoproteins and postprandial lipoproteins as 
risk factors for coronary artery disease. In the following, a short overview of lipid metabolism 
and in particular lipid transport through plasma will be given. 
The lipids that are predominantly found in human plasma are free cholesterol and 
cholesterol esters, triglycerides, free fatty acids and phospholipids. Free cholesterol is the 
principal form present in most body tissues, in particular as a structural component of cell 
membranes. It is a precursor of steroid hormones produced by the adrenal gland and the 
ovary. Cholesterol ester is the storage form of cholesterol found in tissues and also the 
predominant form found in plasma. Cholesterol is produced by many tissues in the body but 
predominantly by the liver and the intestine (newly formed) and is cleared from the body via 
the faeces (free cholesterol and bile acids), cell loss (skin) and urine (steroid hormones). 
Normally there is a balance between production including dietary intake and loss. 
Triglycerides are synthesized from glycerol and free fatty acids in adipose tissue, the liver and 
the intestine (from dietary intake). Their main role is to serve as energy supply for muscles. 
They are transported through plasma as triglycerides in the core of lipoproteins. Free fatty 
acids can also be transported through plasma mostly bound to albumin. Plasma phospholipids 
are mainly derived from the liver and small intestine. They are important components of cell 
membranes. In plasma lipoproteins they playa major role in keeping water-insoluble lipids 
a soluble state. 
Plasma lipoproteins are the principal carriers for the transport of lipid molecules. As 
triglycerides and cholesterol esters are water-insoluble, the spherical shaped lipoproteins 
contain these molecules in their core which is surrounded by a monomolecular surface layer 
consisting of the arnphipathic phospholipids and free cholesterol as well as proteins. Ofthese 
molecules, the hydrophobic part is directed to the lipid core and the hydrophillic part to the 
water phase (plasma), thus making the lipoprotein a water-soluble particle. 
Lipoproteins are commonly, and in this thesis, classified according to their density. This 
density classification defines to a large extent differences in structure, composition and 
metabolism. According to density the following lipoproteins can be distinguished by 
increasing density and decreasing size: chylomicrons; VLDL ~ very low density lipoproteins; 
IDL ~ intermediate density lipoproteins (also: VLDL remnants); LDL ~ low density 
lipoproteins; HDL ~ high density lipoproteins; VHDL ~ very high density lipoproteins (also: 
pre-(3 HDL). 
Apoproteins are the structural protein components of lipoproteins. They play an important 
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role in lipid and lipoprotein metabolism, mainly through their interaction with enzymes and 
receptors. They are, like phospholipids, important for the solubility of lipoproteins in water 
phases. Specific properties of apoproteins are listed in table 1.1. 
Table 1.1. Characteristics and functions of apolipoproteins. 
Apoprotein Chromosome Lipoprotein Function 
A·I II chylomicron, HOL Structural protein of HOL, activates 
LCAT 
A·2 HDL Structural protein of HOL 
A·4 II chylomicron, VHOL Reverse cholesterol transport? 
B·IOO 2 VLDL, IDL, LDL Structural protein of VLOL and HOL, 
ligand for LDL receptor 
B·48 2 chylomicron Essential for chylomicron fonnation 
C·I 19 VLDL,HDL Activator of LCA 1'1 
C·2 19 chylomicrons, VLDL, Cofactor of lipoprotein lipase 
HDL 
C·3 II VLDL,HDL Regulator of lipoprotein lipase 
D 3 HDL ? 
E 19 chylomicron, VLDL, Ligand for remnant and LOL receptors 
IDL, HDL 
Lipid transport by lipoproteins can be subdivided into three major pathways: transport of 
exogenous (dietary) lipids; transport of endogenous lipids; and reverse cholesterol transport. 
In the following these pathways and s.ome of their interrelations will be discussed. Transport 
through the plasma of exogenous (dietary-derived fat) is graphically depicted in figure 1.1. 
After its digestion in the intestinal lumen, dietary fat is taken up by mucosal cells in the 
duodenum and proximal jejunum (figure 1.1). In the enterocytes dietary free fatty acids and 
monoglycerides are reesterified to form triglycerides. Phospholipids are synthesized as well. 
Part of the dietary cholesterol is esterified to cholesterol ester. Subsequently, these lipids are 
combined into chylomicrons. Chylomicrons are the largest and lightest of lipoproteins. Newly 
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formed chylomicrons contain apoproteins A-I, A-IV and B48, large quantities of triglyceride 
and smaller anlOunts of phospholipid and cholesterol ester. They are transported from the 
intestine through the lymphatic system and they enter the circulation via the thoracic duct, 
where they acquire the apoproteins C-II and E from HDL. 
Intestine Chylomicrons Chylomicron 
remnants 
Liver 
> TO E ~ Remnant LPL ~CE receptor 
~ 
Figure 1.1. Exogenous lipid transport. TO = triglyceride; CE = cholesterol ester; A-I, A-IV, BAS, C-JI and 
E are apoproleins. 
Through the enzyme lipoprotein lipase (LPL), which is found on the luminal surface of 
endothelial cells in almost all tissues, and which is activated by the apoprotein C-II, 
triglycerides are hydrolized and taken up by the tissues. The remaining chylomicron remnants 
are then taken up by the liver via receptors that recognize apoprotein E. Apoprotein E enters 
the plasma mainly from the liver. There are three major isoforms namely E2, E3, E4. These 
isoforms are coded for by three different alleles that determine six apoprotein E phenotypes: 
E21E2, E21E3, E21E4, E31E3, E31E4, E41E4. Lipoprotein remnant clearance from the plasma 
is sensitive for apoprotein E polymorphism and is reported to be slower in subjects with 
E21E2 phenotypes. lsoforms E3 and E4 interact readily with the LDL receptor while E2 does 
not. An LDL receptor related protein in the liver may also bind apoprotein E rich lipoproteins 
such as chylomicrons and their remnants. During the delipidation process the apoproteins A 
and C, phospholipids and free cholesterol are transferred from chylomicrons to HDL. All 
cholesterol esters end up in the chylomicron remnants. 
The endogenous pathway (figure 1.2.) encompasses the transport of triglycerides and 
cholesterol as synthesized by the liver. These lipids are transported through the plasma by 
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liver-derived VLDL to sites of storage and utilization. 
Newly formed VLDL contains apoproteins B-IOO, E and C-II, the latter also being 
transferred from HDL. Delipidation of VLDL may be compared with that of chylomicrons. 
During deli pi dation the VLDL lose apoprotein C-II. Most of the VLDL forms lDL (VLDL 
remnants). lDL may subsequently be taken up by the liver through liver receptors recognizing 
apoprotein E; or it may lose more triglycerides via the enzyme hepatic triglyceride lipase 
(HTGL) and apoprotein E to HDL and be converted into LDL. LDL contains free cholesterol 
and cholesterol ester (60 - 70% of total plasma cholesterol) and apoprotein B-IOO as its only 
constituent apoprotein. LDL is cleared from the plasma mainly by the liver through the well 
established LDL-receptors which recognize apoprotein B-IOO as well as apoprotein E. 
Liver 
LDL 
Receptors ------.. 
~ 
IDL 
VLDL 
Figure 1.2. Endogenous lipid transport. TG = triglyceride; CE = cholesterol ester; B-lOO, C-I1 and E are 
apoproleins. VLDL = very low density lipoprotein; IDL = intermediate density lipoprotein; LDL = low 
density lipoprotein; LPL = lipoprotein lipase; HTGL = hepatic triglyceride lipase. 
This receptor plays an important role in cholesterol homeostasis. Whenever cells have excess 
supply via the receptor of free cholesterol molecules they down-regulate the synthesis of LDL 
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receptor protein as well as the synthesis and activity of enzymes (HMG-CoA-reductase) 
involved in de-novo synthesis of cholesterol. 
A surplus of cholesterol in extrahepatic cells can be removed by a process called reverse 
cholesterol transp0l1 for which a putative scheme is shown in figure 1.3. 
HDL plays a key role in reverse cholesterol transport. Newly formed HDL's are precursor 
lipoproteins with a discoidal shape, containing phospholipids, free cholesterol and 
predominantly apoproteins A-I and A-II, but also apoprotein E. There are two commonly 
described sources of HDL. There are nascent HDL of liver and intestinal origin and there are 
discoidal lipoproteins (surface material) which are formed during lipolysis of chylomicrons 
and VLDL. An additional third putative source is shown in figure 1.3. It is proposed to be 
Uver 
r~-<f--' CB1l' 
LDL Receptor 
Related ProteIn ? HDL if LCAT I~ LCAT i 
R,<ep<o, \~ __ G G ~ I Extrahepatic cells 
LJ ,------I -----<t '--------------
'Lll' 
HDL, HDL, VHDL 
Figure 1.3. Reverse cholesterol transport. TO = triglyceride; CE = cholesterol ester; HDL = high density 
lipoprotein; VHDL = very high density lipoprotein; LCAT = lecithin cholesleryl acyl transferase; PLTP = 
phospholipid transfer protein; CETP = cholesterol ester transfer protein. 
formed after conversion of HDL3 particles through phospholipid transfer protein (PLTP). 
Irrespective of the source of discoidal HDL it is capable of taking up free cholesterol from 
extrahepatic cells. This cholesterol is subsequently esterified by the enzyme lecithin 
cholesterol acyl transferase (LCAT) which is activated by apoprotein A-I. Through the uptake 
-10-
Chapter J 
of cholesterol ester the discoidal HDL becomes the spherical HDL3 which may subsequently 
be converted into the bigger HDL2 which is more enriched with cholesterol ester. Through 
cholesterol ester transfer protein (CETP), the cholesterol esters can then be transferred to 
apoprotein B containing lipoproteins and through that route be taken up by the liver. It is not 
exactly known which proportion of HDL is subsequently degraded as a particle. The presence 
of specific cellular binding sites has been proposed (HDL receptor). 
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CHAPTER 2 
POSTPRANDIAL TRIGLYCERIDE RESPONSE IN YOUNG 
ADULT MEN AND FAMILIAL RISK FOR CORONARY ATHEROSCLEROSIS 
Abstract 
2. Postprandial Triglyceride Response in Young 
Adult Men and Familial Risk for Coronary Atherosclerosis 
In this cross-sectional study, the postprandial handling of a standardized oral lipid load 
(mean 397.6 grams), labelled with retinyl palmitate as a marker for chylomicrons and 
chylomicron remnants, was studied in 80 sons (mean age, 24.8 years) of patients with 
clinically manifest and angiographically proven severe coronary artery disease and in 55 sons 
(mean age 23.2 years) of angiographically negative controls. The objective was to determine 
whether an increased risk of coronary artery disease in young adults is related to changes in 
postprandial lipoprotein metabolism. Patients and controls were obtained from coronary 
angiography departments of four central general hospitals in the Netherlands. In both group 
of offspring postprandial levels of semm triglycerides, retinyl palmitate, and total cholesterol 
were measured during a 12 hour period. Both groups showed a marked rise in semm 
triglyceride and retinyl palmitate concentrations after the lipid load, reaching a maximum 4 
to 6 hours postprandially. No changes in postprandial total cholesterol concentrations were 
observed in either group. In sons of patients with coronary artery disease postprandial 
hypertriglyceridemia was prolonged as compared to the sons of controls. Differences between 
groups mainly occurred between 6 and 12 hours after the lipid load. Similar results, although 
smaller and not statistically significant, were obtained with regard to postprandial retinyl 
palmitate, also showing differences mainly after 6 hours. It is concluded that healthy young 
sons of fathers with established coronary artery disease have a prolonged postprandial 
hypertriglyceridemia. These findings support the hypothesis that postprandial lipoprotein 
metabolism plays a role in atherogenesis. 
Introduction 
Atherosclerosis starts early in life (l, 2). Postprandial lipoprotein metabolism is proposed 
to be involved in this process (3). Cholesteryl ester-rich remnants of triglyceride-rich 
lipoproteins may directly promote accumulation of cholesterol esters in the arterial wall (4 -
6). Further, it has been reported (7, 8) that the protective effect of increased levels of high 
density lipoprotein (HDL) cholesterol levels on the risk for coronary artery disease may not 
only be explained by its role in reverse cholesterol transport but also by the relationship 
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between HDL and triglyceride metabolism (9). Plasma triglycerides have an effect on HDL 
composition and HDL-cholesterol levels (10); an inverse relationship between HDL, levels 
and postprandial triglyceride levels has been shown (II). Levels and composition of HDL 
could thus be a reflection of the effectiveness of triglyceride-rich lipoprotein catabolism. A 
deranged metabolism of triglyceride-rich lipoproteins in plasma has been reported in familial 
dysbetalipoproteinemia (12, 13), a disease associated with premature coronary atherosclerosis. 
Studies comparing patients with coronary artery disease and persons without the disease 
have shown that differences with respect to postprandial hypertriglyceridemia (14 - 16) and 
postprandial retinyl palmitate concentrations (a marker of chylomicrons and their remnants) 
are detectable after an oral lipid load (14, 15). These results suggest a delayed clearance of 
these lipoproteins in patients with coronary artery disease. Thus, accumulating evidence 
indicates that postprandial lipemia plays an important role in causing coronary artery disease, 
and the implications with respect to treatment and primary prevention are increasingly being 
recognized (17). 
Postprandial lipoprotein metabolism has not yet been studied in children and young adults 
with an increased risk for coronary atherosclerosis. In our study, male offspring of men with 
clinical manifestations of angiographically proven coronary atherosclerosis were compared 
with the male offspring of men who did not have coronary atherosclerosis (negative results 
after angiography). This approach enabled us to study a group of healthy young adults at a 
high familial risk for developing clinical manifestations of coronary artery disease later in life. 
We assessed whether changes in the triglyceride response to a standardized oral lipid load, 
as reported in patients with coronary artery disease, can also be measured in healthy yOWlg 
male offspring of such patients. 
Methods 
Part/clpants 
Men with very severe coronary artery disease (patients), defined as more than 70% 
occlusion in at least three major coronary vessels were selected from coronary angiography 
databases of cardiology departments of the Zuiderziekenbuis Rotterdanl (1988 - 1991), the 
University Hospital Rotterdanl (1988 - 1989), the Refaj. Ziekenbuis in Dordrecht (1990 -
1991), and the Antonius Ziekenbuis in Nieuwegein (1992), all hospitals situated in the 
Netherlands. Simultaneously, a reference group of men (controls) was selected who at 
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coronary angiography had no or, at most, only minor lesions, defined as 20% stenoses or less 
in all coronary vessels. Further, participants were selected according to the following 
additional criteria: I) age between 45 and 65 years, 2) blood pressure not exceeding 160/100 
nun Hg, 3) absence of liver disease, diabetes mellitus, thyroid disease, and renal disease, 4) 
first coronary angiography within two years before examination for our study, 5) first 
consultation of a physician for cardiac symptoms within 5 years before the examination for 
our study. 
Eligible participants were sent a letter asking whether they had a son 15 to 30 years of age 
and, if so, whether the son was willing to participate in the study. These sons (identified by 
their fathers) received a separate letter inviting them to have an oral lipid loading test. 
Participants also received a short questionnaire about smoking habits, alcohol intake, physical 
activity, and fat intake. 
We screened medical files of 629 patients whose coronary angiographic data met the 
criteria. Of these patients, 19 had died, 46 had diabetes mellitus, 6 had renal disease, 2 had 
thyroid disease, 183 had either no son or sons outside the required age range, 58 could not 
be contacted, 17 had no contact with their children, 78 had a cardiac history exceeding 5 
years, and 63 could not be invited for other reasons (hospitalization, other serious diseases). 
Of 157 families (fathers and sons) who met all the criteria, 55 (either father or son) refused 
to participate in the study (response, 65%), leaving 102 fathers and 139 sons. The latter had 
oral lipid loading tests. The study protocol was approved by the medical ethics conunittees 
of the Zuiderziekenhuis Rotterdam and the University Hospital Rotterdam. Informed consent 
forms were obtained from all participants in the study. 
Baseline measurements 
Fathers were asked to visit the hospital at 9:00 a.m. after fasting for at least 12 hours. 
Fathers responded to a questionnaire about the number of first-degree relatives who had had 
myocardial infarctions and about the medication use at the time of the examination 
(medication was taken to the hospital where the exanlination took place). Systolic blood 
pressure and diastolic blood pressure were measured using a random zero sphyg-momanometer 
(Hawksley, Lancing, United Kingdom). Fasting sernm blood sanlples were drawn by 
arltecubital venipuncture for measurement of levels of triglycerides, total cholesterol, low 
density lipoprotein (LDL) cholesterol, and HDL cholesterol (and its subfractions HDL, and 
HDL,). Height and weight were measured without shoes and without heavy clothing. 
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The sons were invited to come to the hospital, after the same period of fasting, on a separate 
day to have an oral lipid loading test. For sons, questionnaires were used to obtain data about 
use of medication, fat intake, alcohol intake, and smoking habits, referring to a I-month 
period before the examination for this study. Daily total fat intake was calculated from an 81 
item semiquantitative food frequency questionnaire by using a computerized food-composition 
table (17). In the sons, blood samples were taken by antecubital venipuncture for measurement 
of baseline levels of semm triglycerides, total cholesterol, LDL cholesterol, HDL cholesterol 
(and its subfractions HDL, and HDL,), apoprotein A-I, apoprotein A-2, apoprotein B, and 
retinyl palmitate concentrations. This baseline measurement of lipid levels was taken as the 
starting point (10) for the oral lipid loading test. In all of the sons, apolipoprotein E was 
phenotyped. 
Oral lipid loading lesl 
Sons of patients and sons of controls came to the hospital at 7:45 a.m. after an overnight 
fasting of 12 hours. Height and weight were measured first to calculate body surface area. 
Five minutes after the venipuncture for obtaining baseline lipid levels (at 10), all participants 
received a liquid lipid load, which consisted of a mixture of dairy cream (40% fat), egg yolk, 
milk powder, and retinyl palmitate (in aqueous solution) (15). Pru1icipants received the lipid 
load in a dose based on their individual body surface area (77.5 g fat, 0.5 g cholesterol, and 
27.000 IV of retinyl palmitate per square meter of body surface area). The mixture was 
conswned within 15 minutes. 
The participants received an antecubital venous catheter (Venflon, Viggo AB, Helsingborg, 
Sweden), which was kept open during the test period by means of dispensable obturators 
(Venflon). Through this catheter, blood samples were drawn at 2 (1,), 4 (t,), 5 (t,), 6 (t,), 7 
(1,), 8 (t,), 10 (tlO), and 12 (t,,) hours after starting consumption of the oral lipid load. Total 
cholesterol, triglyceride, ruld retinyl palmitate concentrations were determined in serum 
isolated from these samples. During the 12-hour period, other sources of calories were 
withheld from the participants. Because postprandial exercise has been reported to decrease 
postprandial lipemia (19), participants stayed in the hospital and were asked to refrain from 
heavy physical activity during the test period. 
LaboralDlY analyses 
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Serum total cholesterol levels were measured with an automated enzymatic method 
(Boehringer Mannheim, Mannheim, Germany) CHaD-PAP reagent kit (20). Levels of HDL 
cholesterol and LDL cholesterol were measured by the same method after precipitation. For 
HDL cholesterol, the phosphotungstate method according to Burstein (21), with a minor 
modification as described by Grove (22), was used. For LDL cholesterol, precipitation was 
carried out with polyvinylsulphate (Boehringer Mannheim). Tlu'oughout the entire study 
period, results of total cholesterol and HDL cholesterol determinations were within limits of 
the quality control program of the World Health Organization Regional Lipid Reference 
Centre (Prague, Czechoslovakia). Levels of apoprotein A-I and B were assayed using an 
automated immunoturbidimetric method (Kone Diagnostics, Espoo, Finland). Levels of 
apoprotein A-2 was determined by radial immunodiffusion against specific antiserum 
(Boehringer Mannheim, Germany) according to Cheung and Albers (23), with slight 
modifications. All automated analyses were carried out on the Kone Specific Analyzer (Kone 
Instruments) using frozen (-20°C) selUm samples. High-density lipoprotein, and HDL, 
subfractions in serum were assayed as described by Gidez and colleagues (24), with slight 
modifications. High-density lipoprotein, and HDL, subfractions were separated using stepwise 
precipitation of apoprotein B containing lipoproteins with heparinelMn" and HDL, with 
dextran sulphate. Apolipoprotein E phenotyping was done by isoelectric focusing of 
delipidated serum followed by immunoblotting, using apolipoprotein E antiserum as first 
antibodies (25). Retinyl palmitate analyses were performed as described previously by Groot 
and colleagues (15). 
Statistical analysis 
Mean ± SDs were calculated for baseline characteristics of all fanlily members. The total 
cholesterollHDL cholesterol and LDL cholesterollHDL cholesterol ratios were calculated for 
fathers and sons, and the apoprotein A-l/apoprotein B ratio was calculated for sons. Baseline 
differences between patients and controls, as well as their respective sons were evaluated using 
the two group I-test, or the Marm-Whitney U test when appropriate. Differences in 
postprandial responses between sons of patients and sons of controls with regard to 
triglycerides and retinyl palmitate were evaluated with age-adjusted repeated-measures analysis 
to determine if group differences at each postprandial measurement time differed significantly 
from group differences at any other measurement time. Subsequently, linear regression 
analysis was used to compare mean group postprandial responses. Adjustments were made for 
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age, HDL, cholesterol, HDL, cholesterol, apolipoprotein E phenotype, and daily total fat 
intake. This was done at each postprandial measurement time (I, to t,,) and for areas under 
the curve for several time (2: 2 hour) intervals. In the analyses both individual postprandial 
measurements and areas under the curve were evaluated after subtracting the initial individual 
values (t,,) for triglycerides and retinyl palmitate from all respective postprandial measure-
ments, yielding the net postprandial change. 
Results 
Two sons of patients did not tolerate the oral lipid load because of gastrointestinal problems 
and were excluded from the study. All other participants tolerated the fat load very well and 
did not have gastrointestinal symptoms or steatorrhea during or after the tes!. 
Two (other than already excluded) participants had baseline triglyceride values of2.52 and 
2.45 mmol/L, respectively. The first participant had six measurements of postprandial retinyl 
palmitate measurements that were more than 3 to 5 standard deviations above the mean, and 
the latter participant had five measurements of postprandial triglyceride measurements that 
were more than 3 to 5 standard deviations above the mean. Because of the marked effect of 
these outliers on the precision of the results obtained in the group as a whole, these two 
participants were excluded from analyses. 
Baseline characteristics are given for both groups of fathers and sons in table 2.1. No 
statistically significant differences were noted between patients and controls. Sons of patients 
were slightly older and had a lower total fat intake. All patients (n~59) had had coronary 
angiography for evaluation of symptoms of chest pain. For controls, the indications for 
coronary angiography were symptoms of chest pain (n~30), evaluation of cardiac valves 
(n~7), suspected cardiomyopathy (n~5), and ventricular septum defect (n~ 1). At the time of 
coronary angiography, 19 (32.2%) patients and 11 (25.6%) controls were treated for 
hypertension. The average time elapsed between the date of the coronary angiography and 
date of the examination was 13.2 ± 0.9 months (mean ± SE) for patients and 13.2 ± 1.1 
months for the controls. 
Baseline serum measurements after an overnight fast are given for both groups in table 2.2. 
As expected, patients had higher serum levels of total cholesterol, LDL cholesterol, and 
triglycerides and had higher total cholesterollHDL cholesterol and LDL cholesterollHDL 
cholesterol ratios than did controls. Levels of HDL cholesterol and its subfractions tended to 
be slightly lower in patients than in controls (Table 2.2). Compared with sons of controls, 
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Table 2.1. Baseline cha:racterist:ics of fathers and SODS. 
Cha:racterist:ic Fathers 
Patients Controls P value 
(n ~ 59) (n ~ 43) 
Age (y) 555 ± 0.8 53.9 ± 12 >02 
Height (em) 176.4 ± 0.7 1783 ± 12 0.15 
Weight (kg) 79.4 ± 12 79.8 ± 1.6 >02 
, Quetelet-index (kgfm') 25.4 ± 03 25.1 ± 0.4 >02 
tv 
~ Systolic blood pressure (rom Hg) 125.4 ± IS 128.5 ± 2.4 >02 
Diastolic blood pressure (rom Hg) 82.6 ± 1.5 823 ± 1.7 >02 
Hypertension treatment (%) 322 25.6 >02 
Smoking (%) 153 27.9 0.19 
Alcohol use (%) 
Alcohol intake (gfd) 
Total tat intake (gf d) 
Values are mean ± SD. where appropriate. P values compare patients and controls. 
SODS of 
Patients Controls 
(n~80) (n~5) 
24.8 ± 0.6 232 ± 0.6 
1832 ± 0.7 183.4 ± 0.9 
78.0 ± 12 753 ± 13 
232 ± 0.03 22.4 ± 0.03 
120.9 ± 1.4 118.1 ± 22 
77.6 ± 1.0 75.0 ± 1.8 
28.8 31.6 
86.3 78.9 
11.4 ± 1.7 9.6 ± IS 
133.6 ± 9.0 169.8 ± 13.9 
P value 
0.049 
>02 
0.19 
0.12 
0.19 
0.10 
>02 
>02 
>02 
0.012 
9 {l 
~ 
'" 
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Table 2.2. Baseline serum measurements in fathers and SODS. 
Variable Fathers Sons of 
Patients Controls P value Patients Controls P value 
(n = 59) (n = 43) (n = 80) (n = 55) 
Total cholesterol (mg/dL) 2633 ± 5.0 2412 ± 5.9 0.006 200.0 ± 3.7 195.8 ± 45 >02 
WL cholesterol (mg/dL) 193.4 ± 4.7 169.6 ± 55 0.002 137.4 ± 3.8 130.8 ± 45 >02 
IIDL cholesterol (mg/dL) 42.8 ± 1.4 45.4 ± 1.6 >02 43.4 ± 1.0 45.7 ± 13 0.15 
IIDI., cholesterol (mg/dL) 73 ± 0.7 8.6 ± 0.9 >02 7.7 ± 0.5 6.7 ± 0.7 >02 
IIDI., cholesterol (mg/dL) 36.0 ± 0.9 36.6 ± l.l >02 35.7 ± 0.8 38.9 ± 1.0 0.016 
Triglycerides (romol/L) 2.01 ± 0.12 1.53 ± 0.15 0.015 1.09 ± 0.06 !.I5 ± 0.08 >02 
Total cholesterolJHDL cholesterol 6.6 ± 03 5.6 ± 03 0.015 4.8 ± 0.1 4.4 ± 02 0.09 
LDL cholesterollHDL cholesterol 4.8 ± 02 3.9 ± 03 0.001 33 ± 0.1 3.0 ± 02 0.10 
Apoprotein A-I (mg/dL) ll5.7 ± 2.4 120.1 ± 3.0 >02 
Apoprotein A-2 (mg/dL) 43.1 ± 0.9 482 ± l.l 0.001 
Apoprotein B (mg/dL) 85.3 ± 2.3 85.6 ± 2.8 >02 
Apoprotein A~I/Apoprotein B 1.45 ± 0.05 1.45 ± 0.06 >02 
Retinyl palmitate (J<g/dL) 2.8 ± 05 2.4 ± 0.6 >02 
Values are mean ± SE, adjusted for age. LDL = Low-density lipoprotein; HDL = High-density lipoprotein. P values compare patients and 
controls. 9 {l 
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sons of patients had a somewhat less favorable lipoprotein and apoprotein profiles (not 
statistically significant). Sons of patients had significantly decreased levels of HDL, 
cholesterol (p~O.OI6) and apoprotein A-2 (p~O.OOI) when compared with controls. The 
frequencies of apolipoprotein E phenotypes did not differ between sons of patients and sons 
of controls. Apoprotein E2 alleles were present in 8 sons of controls and 6 sons of patients, 
I of whom was of the E2fE2 phenotype. TillS participant was not an outlier with regard either 
to baseline lipid profile or postprandial data. 
The mean fat load ingested by sons of patients was 399.4 ± 3.2 g (mean ± SE) by and by 
sons of controls was 395.1 ± 3.8 g. None of the sons in both groups had previous or current 
diseases or received medication known to have an effect on lipoprotein metabolism. 
Serum Triglyceride Serum Retinyl Palmitate Serum Total Cholesterol 
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Figure 2.1. Serum lipid levels in young adult men after an oral fat load. Levels of postprandial serum 
triglyceride (left), retlnyl palmitate (middle), and total cholesterol (right) are mean values adjusted for age. To 
convert cholesterol levels to mmollL, multiply by 0.02586. CAD "" COrollary artery disease; CAD + and CAD-
refer to sons whose fathers do and do not have coronary artery disease, respectively. 
Figure 2.1 shows age-adjusted mean postprandial curves for levels of triglyceride, retinyl 
pahTIitate, and total cholesterol. Figure 2.1 (left panel) shows mean postprandial triglyceride 
curves for sons of patients and sons of controls. In both groups, oral lipid loading led to 
markedly similar increases in triglyceride concentrations, maximum levels appeared between 
4 to 6 hours postprandially. After 12 hours, triglyceride concentrations had decreased below 
initial levels. The age-adjusted repeated-measures analysis showed an interaction effect 
between group and time (X2~19.2; p~O.OI4), indicating that the two curves were significantly 
different from each other. 
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In Figure 2.1 (middle panel) the mean postprandial retinyl palmitate curves are shown. 
Retiny! palmitate concentrations increased from virtually zero in both groups to reach 
maximum concentrations between 5 and 6 hours postprandially. Thereafter, retinyl palmitate 
concentrations decreased to levels at t" that were approximately tenfold the initial levels at 
to. The repeatedMmeasures analysis for these curves indicated no significant difference 
(X'~6.42; p~O.60). 
In Figure 2.1. (right panel) curves are shown for postprandial total cholesterol responses. 
Sons of patients had higher mean total cholesterol levels at to than did sons of controls, and 
this difference remained remarkably constant during the lipid loading test, showing no 
significant response to the intervention. The age-adjusted difference in mean cholesterol levels 
(mean of all cholesterol measurements) was 2.3 ± 5.87 mg/dL (mean ± SE, p~O.70). 
A slight difference in age was noted between sons of patients and sons of controls. Age has 
been shown to have an effect on postprandial lipoprotein changes (26) and postprandial retinyl 
ester response (27), and therefore the differences in postprandial response between sons of 
patients and sons of controls were adjusted for age. 
Table 2.3 shows the age-adjusted differences between net postprandial changes in 
triglyceride and retinyl pahnitate responses between sons of patients and sons of controls. 
Triglyceride response differences showed a maximum at t5, and reached significance at times 
t" t", and t". With respect to retinyl palmitate, sons of patients and sons of controls showed 
a slight difference in response, increasing to a maximum at ts to t6' None of the retinyl 
palmitate differences was found to be statistically significant. 
In Figure 2.2.A, age-adjusted areas under the curves for 2-hour time intervals are given for 
postprandial triglyceride responses in sons of patients and sons of controls. Peak areas for both 
groups were found in interval t4 to t6' Differences were mainly found in intervals t6 to tg, tg 
to t lO, and t" to t". In the latter interval, the triglyceride response of sons of controls 
decreased below to (baseline) levels to a greater extent than in sons of patients. Figure 2.2.B 
shows total area under the curves for 10-, 8-, 6-, and 4-hour time intervals up to t". For all 
intervals, areas under the curve differed significantly between the groups. Figures 2.2.C and 
2.2.D show similar data for retinyl palmitate responses in the groups. For 2-hour intervals and 
larger intervals, areas under the curves for sons of patients tended to be higher, although 
differences did not reach statistical significance. 
The results for postprandial retinyl palmitate as well as triglycerides did not materially 
change after adjustment for baseline HDL, cholesterol levels, HDL, cholesterol levels, and 
apolipoprotein E phenotype. Total fat intake was decreased in sons of patients compared with 
sons of controls (p~O.OI2; Table 2.1). Adjustment for this difference in postprandial analyses 
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Table 2.3. Postprandial triglyceride and retinyl palmitate responses in sons of patients with coronary artery disease and sons of controls. 
Time (Il) Triglycerides (mmol/l) Retinyl palmi""e (pgldL) 
Sons of Sons of Difference Sons of Sons of Difference 
patients controls (95% Cl) patients controls (95% Cl) 
(n=80) (n=65) (n=80) (n=65) 
2 Ll7 ± 0.08 1.04 ± 0.09 0.13 (-0.11 to 037) 353 ± 3.0 353 ± 3.6 0.03 (-9.1 to 92) 
4 1.81 ± 0.13 1.64 ± 0.16 0.17 (-024 to 058) 103.9 ± 6.0 101.7 ± 73 23 (-163 to 20.8) 
5 1.89 ± 0.15 1.46 ± 0.18 0.43 (-0.02 to 0.88) 122.8 ± 7.4 110.8 ± 9.0 12.0 (-11.0 to 34.9) 
6 1.40 ± 0.12 1.06 ± 0.15 034 (-0.03 to 0.72) 124.6 ± 8.1 106.6 ± 9.8 17.9 (-72 to 43.0) 
7 0.87 ± 0.10 058 ± 0.13 029 (-0.03 to 0.61) 100.0 ± 72 90.4 ± 8.7 9.6 (-12.6 to 31.8) 
8 0.54 ± 0.09 0.19 ± 0.11 035 (0.07 to 0.62) 80.7 ± 6.9 70.6 ± 8.4 10.0 (-11.4 to 31.5) 
10 -0.12 ± 0.05 -033 ± 0.06 021 (0.06 to 036) 46.0 ± 4.6 40.0 ± 5.5 6.0 (-8.1 to 20.1) 
12 -029 ± 0.04 -0.42 ± 0.05 0.13 (0.01 to 026) 262±23 222 ± 2.7 4.0 (-3.1 to 11.1) 
Triglyceride and retinyl palmitate values are mean ± SE, adjusted for age. Age-.adjusted mean differences (values of sons of patients minus values 
of sons of controls) are given with their corresponding 95% CIs. 
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Figure 2.2. Age adjusted areas under the curve for levels of postprandial triglyceride and retinyl palmitate. A. 
Areas under the curve for postprandial triglyceride levels for 2-hour time intervals. B. Areas under the curve for 
larger time intervals. C and D. Areas under the curve for postprandial retinyl palmitate. Closed bars ~ sons of 
patients with coronary artery disease; open bars"" sons of controls (those without coronary artery disease) . 
• = p<O.05; t = p<O.Ol. 
did not change the results, with adjusted group differences in triglyceride levels at t, of 0.32 
mmollL [95% CI, 0.04 to 0.59], at tlO of 0.2 mmollL [95% CI, 0.047 to 0.36], and at t" of 
0.1 mmollL [95% CI, 0.002 to 0.26]. All sons were asked whether they had changed their 
lifestyles with regard to smoking habits, physical activity, and fat intake since their fathers had 
had cardiac examination. None of the group differences was statistically significant. Also, a 
similar analysis of sons who reported to live separately from their fathers at the time of 
examination (45 sons of patients [56%] and 24 sons of controls [42%] yielded no significant 
group differences with respect to lifestyle changes. An analysis of postprandial data in these 
groups showed similar results, with sons of patients having higher triglyceride levels at t, 
(difference, 0.47 mmollL; 95% CI, -0.018 to 0.95) and t10 (difference, 0.29 mmollL; 95% CI, 
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O.oJ5 to 0.57). When analyses were done for participants with normal levels oftriglycerides 
only (serum triglyceride:; 2.28 mmollL), thereby excluding 13 participants, no major changes 
in the results were found. 
Discussion 
Familial aggregation of risk factors for coronary artery disease is well established, and the 
offspring of patients with very severe coronary artery disease are at increased risk for this 
disease (28, 29). We assessed whether this increased familial risk was related to postprandial 
metabolic handling of an oral fat load in healthy young male adults whose fathers had severe 
coronary artery disease. Baseline measurements showed that sons of patients and sons of 
controls had similar levels of lipids and apolipoproteins, only levels of HDL, cholesterol and 
apoprotein A-2 were significantly decreased in sons of patients. 
After oral lipid loading, however, prolonged postprandial hypertriglyceridemia was observed 
in the sons of patients, amounting to statistically significant group differences of 0.35 mmollL 
after 8 hours, 0.21 mmollL after 10 hours, and 0.13 mmollL after 12 hours. Differences in 
postprandial triglyceride levels between the groups were mainly observed in the declining part 
of the curves, which suggests a delayed clearance of triglyceride from plasma. Data on 
postprandial retinyl palmitate responses also suggest similar differences for postprandial 
triglyceride levels with regard to the direction of the difference and the postprandial period 
in which differences appeared. However, these latter differences were not statistically 
significant. 
A marked contrast between patients with coronary artery disease and controls with regard 
to angiographlc findings was chosen to minimize the chance of misclassification of patients 
and also because of the anticipated subtle differences between both groups of offspring. 
Considering the efforts asked on a strictly voluntary basis from fathers, and particularly their 
offspring, the response rate of 65% in this study is satisfactory. However, it is possible that 
postprandial lipoprotein metabolism in these young healthy participants was in some way 
differentially related to the response in both groups and, although unlikely, it is possible that 
selection mechanisms have affected the findings. Because contraceptive steroids have an effect 
on postprandial lipid metabolism in young health women (30), we restricted the study to sons. 
Chylomicron metabolism is thought to occur essentially in two successive steps. First, these 
particles interact with lipoprotein lipase, an enzyme which is located on capillary endothelial 
surfaces of various tissues, including heart, skeletal muscle, and adipose tissue (31). This lipase 
catalyses the hydrolysis of triglycerides, and this results in uptake of free fatty acids by tissues 
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(32). Thereafter, resulting chylomicron remnant particles are taken up relatively quickly and 
efficiently (33) by parenchymal cells in the liver. The importance of this process, with regard 
to atherogenesis, is that any hampering in this course of events might lead to higher plasma 
levels of atherogenic triglyceride-rich Iipiproteins and their remnants. 
In principle, the oral lipid loading test cannot distinguish between mechanisms involved in 
chylomicron entry into and clearance of chylomicrons and their remnants from the circulation. 
In our study, no attempt was made to assess differences between intestinal lipid absorption in 
the two groups of young adult men. In a study of postprandial lipoprotein metabolism, 
Weintraub and colleagues (13) showed that gastrointestinal transit time was similar in normal 
participants and participants with different types of hyperlipoproteinemias. Previous studies 
(14 - 16) showed that mean triglyceride and mean retinyl palmitate response curves are similar 
during the first 4 hours postprandially when comparing patients and controls, which we also 
found in our study in sons of such patients. This suggests that differences in fat absorption or 
in intestinal secretion, if any, are not likely to explain group differences during the second half 
of the test period. 
Retinyl pahnitate is a useful marker of the metabolism of intestinally derived triglyceride-
rich lipoproteins and their remnants because it is incorporated into the core of these 
lipoproteins (34) and retained within them until their irreversible clearance from plasma by 
the liver (35). Although a considerable postprandial exchange between lipoproteins of total 
retinyl esters has been reported in man (36), little exchange of retinyl pahnitate between 
intestinally derived lipoproteins and other lipoproteins has been shown (37, 38). In our study, 
retinyl palmitate responses showed considerable interindividual variation in both groups, which 
may explain why differences between group responses did not reach statistical significance. 
An alternative explanation might be that the postprandial retinyl ester response is greater in 
older persons than in YOlmger persons (27), thus making it more difficult to detect group 
differences in the young. Further, postprandial hypertriglyceridemia may partly be induced by 
endogenous very-low-density lipoprotein and its remnants (39), which do not contain retinyl 
palmitate. Finally, significant group differences in retinyl palmitate may emerge after the 12-
hour measuring period used in the present study and, thus, may have been missed (14). 
In our study, data were analyzed after subtracting individual fasting triglyceride levels and 
retinyl palmitate levels from respective subsequent measurements. Differences in body height 
and weight were considered by standardizing the oral lipid load to body surface area as a 
function of body height and weight. Possible confounding effects of age, HDL, cholesterol 
levels, HDL, cholesterol levels, and apolipoprotein E phenotype were adjusted for in the 
analysis. Apolipoprotein E polymorphism has recently been shown to have an effect on 
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postprandial retinyl palmitate concentrations (40). Adjustment for these factors did not 
materially change results with regard to group differences. 
The hypothesis that postprandial lipoprotein metabolism plays an essential role in 
atherogenesis was first postulated by Zilversmit (3). This hypothesis was adressed in recent 
studies in humans (14 - 16) in which patients with coronary artery disease were compared with 
controls with respect to postprandial lipemia; the study found that patients had higher 
postprandial triglyceride and retinyl palmitate responses. In another study, Simons and 
colleagues (41) fOlmd that 4 hours postprandially the apoprotein B48/apoprotein BIOO ratio, 
used as a relative measure of chylomicrons and chylomicron renlllants in plasma, was higher 
in patients with coronary artery disease than in controls. In addition, a positive correlation 
between the postprandial triglyceride response to an oral lipid load and carotid artery wall 
thickness has been reported (42). These studies suggest that prolonged presence oftriglyceride-
rich lipoproteins in plasma may indeed playa role in atherogenesis. 
The design of our investigation enabled us to examine a group of young adult men at high 
familial risk for developing clinical manifestations of coronary artery disease much later in 
life. One advantage of the design of this study is that sons of these patients are not exposed 
to treatments such as medication that could alter triglyceride metabolism, as might occur when 
patients themselves are studied. However, if patients have been given advice about lifestyle, 
this may in turn have led to lifestyle changes in their sons. In both groups of sons, most 
reported not to have changed their levels of physical activity, smoking behavior, and fat intake 
since their fathers were examined for cardiac symptoms; approximately equal proportions 
reported to eat less fat. Additionally, an analysis of sons living separately from their fathers, 
who are assumed to be less influenced by lifestyle advice given to their fathers, yielded similar 
results with statistically significant differences in the declining part of the triglyceride curves, 
despite the considerably decreased number of participants. Although no major differences were 
noted with regard to reported fat intake, daily total fat intake as calculated from the food 
frequency questionnaire was significantly decreased in sons of patients compared with sons 
of controls. Long- and short-term effects of fat intake on postprandial lipoprotein levels have 
been reported (43), but in our study, adjustment for daily total fat intake did not change 
postprandial results. Thus, we believe that changes in physical activity, smoking behavior, and 
fat intake are not likely to explain the postprandial differences found between both groups of 
sons. 
Our data show that healthy young sons whose fathers have established coronary artery 
disease have prolonged postprandial hypertriglyceridemia. Tltis finding suggests that changes 
in postprandial lipid metabolism are associated with familial risk for coronary atherosclerosis. 
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In an editorial accompanying the publication of the study described in chapter 2 (I), the 
possible explanations for postprandial offspring group differences found in this study were 
discussed. These included mechanisms by which the differences could be acquired or genetic, 
the latter being either monogenic of polygenic. It was proposed that a monogenic defect may 
exist that affects triglyceride metabolism. In that case the postprandial group differences might 
be explained by much more marked responses in a few sons who inherited this defect rather 
than a general shift of the distribution of responses for the gl'Oup as a whole. In the reaction 
described below this possibility was analyzed. 
Triglyceride levels in sons of patients with coronary artery disease (Re) 
To the editor: We thank Dr. Grundy (l) for his supportive and useful discussion of our 
report (2), in which he considers various explanations for the prolonged postprandial 
hypertriglyceridemic response in the sons of patients with coronary artery disease. Dr. Grundy 
suggests that we examine the possible bimodality of responses in the offspring of patients, a 
bimodality that would theoretically emerge if group differences could be attributed to a 
heterozygous monogenic defect of triglyceride metabolism in patients. Given this monogenic 
hypothesis, a subgroup of patients having the gene would transmit it to 50% of their offspring. 
Consequently, a subgroup of sons would have marked postprandial responses, and Dr. Grundy 
suggests that these responses may explain the effect that we found. 
A classic debate between Platt and Pickering (reviewed in reference 3) on the mode of 
transmission of primary hypertension on the basis of the shapes of blood pressure distribution 
curves has shown that bimodality, as distinct from left-skewing, in such curves is not easily 
proved. Further, a familially acquired abnormality in only a subgroup of families could 
theoretically lead to a similar bimodality. This and the relatively small sample size of our 
study initially led us not to engage in such an analysis. An alternative approach in unravelling 
putative modes of inheritance is segregation analysis, but such an analysis would not be overly 
informative in tillS case because of the limited number of siblings in our study. Nevertheless, 
we have attempted to address Dr. Grundy's suggestion. Figure 2.3 shows the frequency 
distribution of areas under the curve of the triglyceride response for sons of patients 6 to 12 
hours after lipid loading. Although not a normal distribution, the mnnber of observations does 
not allow definite conclusions on modality. Moreover, if those with a response above the 
arrow (n=7) are exluded from the analysis, the difference between offspring groups remains 
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of borderline significance (difference, 0.78 rumol x hJL; 95% CI, -0.015 to 1.574). Thus, it 
seems that offspring group differences cannot be fully explained by a subgroup of sons of 
patients with markedly high postprandial responses. Although this analysis must be evaluated 
with some caution, the monogenic mechanism as the sale explanation for prolonged 
postprandial hypertriglyceridemia does not appear to be supp011ed by our data. 
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Figure 2.3, Frequency distribution of area under the curve (l nunol x hIL intervals) for sons of patients with 
coronary artery disease. t6-t12 '" triglyceride responses 6 to 12 hours after lipid loading. Patients with responses 
higher than that indicated by the arrow were excluded from the analysis. 
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CHAPTER 3 
LIPOPROTEINS AND APOLIPOPROTEINS IN YOUNG ADULT MEN 
AND WOMEN AND RISK FOR CORONARY ATHEROSCLEROSIS 
Abstract 
3. Lipoproteins and Apolipoproteins in Young Adult Men 
and Women and Risk for Coronary Atherosclerosis 
Atherosclerotic lesions develop early in life. The role of lipoproteins and apolipoproteins in 
the atherosclerotic process at a young age is not completely elucidated. The aim of the present 
study was to assess lipoprotein and apolipoprotein levels in young adults in relation to 
coronary atherosclerosis in their parents. 
We studied the offspring of patients who were admitted for diagnostic coronary angiography 
in several general hospitals in the Netherlands. From these patients we selected a group of 
male patients (n~90), who had severe coronary atherosclerosis at angiography, and a reference 
group of male patients (n~62), who had no coronary atherosclerosis at angiography. 
Lipoprotein and apolipoprotein levels were determined in 115 sons and 73 daughters of the 
patients with severe coronary atherosclerosis. These were compared to levels in 68 sons and 
47 daughters of men from the reference group. 
Lower levels of HDL, cholesterol and apolipoprotein A2 were found in sons of patients 
suffering from severe coronary atherosclerosis. Similar differences were observed in daughters 
of such patients without, however, achieving statistical significance. 
Our findings add to the growing evidence that changes in lipoprotein and apolipoprotein 
levels can be detected relatively early in life. It is concluded that the low levels of HDL, 
cholesterol and apolipoprotein A2 found in sons of patients with severe coronary sclerosis may 
playa role in the development of coronary atherosclerosis. 
Introduction 
Cholesterol levels and other risk factors in the young are related to atherosclerotic lesions 
which may develop early in life (1-4). Total serum cholesterol levels measured in adolescent 
men have also been shown to be associated to the occurrence of manifest cardiovascular 
disease later in life (5). Less is known, however, about the role of lipoproteins and 
apolipoproteins at a young age. One way to study the relation between lipoproteins and 
apolipoproteins in relation to coronary artery disease is to examine the offspring of parents 
who suffer from coronary atherosclerosis. Coronary heart disease and its risk factors tend to 
aggregate in families (6-9). Recent prospective studies have shown that a parental history of 
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myocardial infarction is a risk factor for coronary artery disease, which is independent from 
classical cardiovascular risk factors (10,11). Thus, there may be other as yet unknown genetic 
or acquired risk factor for coronary artery disease. 
In the present study lipoproteins and apolipoproteins in 188 children of fathers who suffered 
from severe clinically manifest and angiographically proven coronary atherosclerosis were 
compared to levels measured in 115 children of fathers who did not have coronary 
atherosclerosis at diagnostic coronary angiography. 
Subjects and methods 
From 1987 to 1992 two groups of male patients were selected from the coronary 
angiography databases of the cardiology departments of the Zuiderziekenhuis in Rotterdanl 
(1987 - 1991), the Academic Hospital Dijkzigt in Rotterdam (1988 - 1989), the Refaja 
Ziekenhuis in Dordrecht (1990 - 1991), and the Antonius Hospital in Nieuwegein (1992), the 
Netherlands. The index group had severe coronary atherosclerosis, defined as more than 70% 
stenosis in at least three major coronary vessels at angiography (CAD+ fathers). A reference 
group had no or only minor angiographic lesions, defined as 20% stenosis or less in all 
coronary vessels (CAD- fathers). Additional criteria for both groups of men were: (I) age 
between 45 and 65 years, (2) blood pressure not exceeding 160/100 mmHg, (3) absence of 
liver disease, diabetes mellitus, thyroid disease, and renal disease, (4) coronary angiography 
within two years preceding examination, (5) first consultation of a physician for cardiac 
complaints within five years preceding examination for this study. Eligible subjects were sent 
a letter in which they, their children and the mothers of their children were invited to 
participate in the study. The average time elapsed since catheterisation to the present 
examination was 12.6 ± 6.0 months (mean ± SD) for CAD+ fathers and 13.6 ± 6.4 for CAD-
fathers. 
Measurements 
The fathers, mothers, sons and daughters were asked to come to the hospital at 9.00 a.m. 
after fasting for at least 12 hours. Systolic blood pressure (SBP) and diastolic blood pressure 
(DBP) were measured using a random zero sphygmomanometer (Hawksley). Fasting senull 
blood samples were drawn by antecubital venipuncture for measurement of triglycerides, total 
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cholesterol, low density lipoprotein cholesterol (LDL cholesterol), high density lipoprotein 
cholesterol (HDL cholesterol), its subfractions HDL, cholesterol and HDL, cholesterol, 
apolipoprotein AI, apolipoprotein A2, and apolipoprotein B. Height and weight were measured 
without shoes and heavy clothing. The Quetelet-index was calculated as weight (kg) divided 
by the square of height (m'). 
The fathers answered a questionnaire with questions on the number of first degree relatives 
who had suffered from myocardial infarctions and on the use of medication at the time of 
exanlination (medication was taken to the hospital). Parents and children answered a 
questionnaire referring to a one month period prior to the examination, with questions on use 
of medication, habitual alcohol intake, coffee intake, and smoking habits. In addition, mothers 
and daughters were asked about the use of oral contraceptives, menstrual cycle and 
pregnancies. Sons and daughters were also asked about changes in lifestyle (physical activity, 
smoking behavior, and fat intake) since their fathers had first been exanlined by a physician 
for cardiac complaints. In the first 50 families selected for this study all members were invited 
for baseline measurements only. In these families the response rate was 92%. In the next 102 
families the sons (80 sons of CAD+ fathers and 57 sons of CAD- fathers) were invited to 
come to the hospital on a separate day because of their simultaneous involvement in another 
study for which the criteria and conditions were similar to those in the present study. The sons 
as well as the daughters from these 102 families underwent the same measurements under the 
same conditions as the offspring of the first 50 fanlilies. The protocol of the extended study 
required sons from these 102 families to stay in the hospital for 12 hours, and the response 
rate was lower (65%) in this group of sons. 
Laboratory analysis 
Serum total cholesterol was measured with an automated enzymatic method, using the 
Boehringer Mammeim (FRG) CHOD-PAP reagent kit (12). HDL and LDL cholesterol were 
measured by the same method after precipitation. For HDL cholesterol the phosphotungstate 
method according to Burstein (13), with a minor modification as described by Grove (14) was 
used. For LDL cholesterol precipitation was carried out with polyvinylsulphate (Boehringer 
Mannheim, FRG). Throughout the entire study period the results of both total cholesterol and 
HDL cholesterol were within limits of the quality control progranlllle of the WHO Regional 
Lipid Reference Centre (prague, Czechoslovakia). Apolipoproteins Al and B were assayed by 
an automated immunoturbidimetric method (Kone Diagnostics, Espoo, Finland). 
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Apolipoprotein A2 was determined by radial inununodiffusion against specific antisenun 
(Boehringer Mannbeim, FRO) according to Cheung and Albers, with slight modifications (15). 
All automated analyses were carried out on the Kone Specific Analyzer (Kone Instruments, 
Espoo, Finland) using frozen (-20°C) serum samples. HDL, and HDL, cholesterol subfractions 
in serum were assayed as described by Gidez et al. (16) with slight modifications. HDL, and 
HDL, cholesterol subfractions were separated using stepwize precipitation of apolipoprotein 
B containing lipoproteins with heparin/Mn" in two steps and HDL, with dextran-sulphate. 
Statistical methods 
Mean values and standard deviations were calculated for all characteristics of the two groups 
of fathers, mothers, sons and daughters, separately. Mean group differences in baseline 
characteristics were tested with the t-test or MarUl-Whitney U test when appropriate, and the 
X' test for proportional data. All further analyses were adjusted for age. Adjusted mean values 
for lipoproteins levels in parents and offspring were obtained using linear regression analysis 
with the (apo)lipoprotein level as the dependent and a group indicator and age as the 
independent variables. The associations between (apo)lipoprotein levels in family members 
were assessed by linear regression analysis. This analysis included fathers and mothers and the 
first sons or daughters taking part in the study. Because of the dependency of measurements 
between brothers and between sisters within families, group differences between lipoprotein 
values in the offspring were analyzed u,ing a repeated measures analysis of variance where 
fathers were considered the sampling units (BMDP, 1990). In this analysis, lipoprotein values 
in sons and daughters were considered repeated measures within fathers. In the repeated 
measures analysis mean lipoprotein levels were adjusted for age, as well as for a combination 
of age, height, weight, systolic blood pressure, diastolic blood pressure, smoking, alcohol 
intake and in daughters the use of oral contraceptives. 
Results 
Table 3.1 shows the characteristics of the CAD+ patients and the CAD- reference group, as 
well as those of their family members. On average CAD+ patients and their family members 
were older. Significant differences were present in a number of characteristics. Fathers of the 
CAD- group were taller, the proportion of smoking mothers was higher in the CAD- group, 
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systolic and diastolic blood pressure were on average higher in sons of CAD+ and the 
proportions of smokers and users of coffee as well as the Quetelet-index were higher in 
daughters of CAD+. After adjustment for age only the group differences in smoking in 
mothers and diastolic blood pressure in sons remained significant. 
In table 3.2 the mean (apo)lipoprotein levels are given for fathers and mothers from both 
groups. There were considerable differences with regard to lipids and apolipoproteins between 
the two groups of fathers. CAD+ fathers had higher levels of total and LDL cholesterol, of 
triglycerides and of apolipoprotein B and lower levels of HDL cholesterol than CAD- fathers. 
Further adjustment for other risk factors did not materially change these results (data not 
shown). In the mothers the only difference was a higher triglyceride level in the wives of 
CAD+ and a higher apolipoprotein A I after adjustment for other risk factors. 
Table 3.3 shows the mean age adjusted lipoprotein and apolipoprotein values for the sons 
and the daughters. Sons and daughters of CAD+ fathers on average had adverse lipoprotein 
and apolipoprotein levels compared with sons and daughters of CAD- fathers. 
Table 3.4 gives the mean differences between the groups of sons and daughters with regard 
to lipoprotein and apolipoprotein levels, as analyzed with repeated measures analysis of 
variance. Sons of CAD+ fathers had significantly lower levels of HDL, cholesterol and 
significantly lower levels of apolipoprotein A2. None of the other group differences was 
statistically significant. HDL, cholesterol and apolipoprotein A2 levels were also somewhat 
lower in daughters of CAD+ fathers, but none of these as well as other differences were 
statistically significant. An additional repeated measures analysis in which all families were 
excluded in which either one or both parents and one or more offspring had total cholesterol 
levels exceeding 300 mgldl yielded similar results. When all families were excluded in which 
one of the parents had a total cholesterol level exceeding 300 mgldl similar results were 
observed with significantly lower levels of HDL, cholesterol and apolipoprotein A2 in sons 
of CAD+ fathers. 
For total cholesterol there were significant associations between levels in fathers and sons 
(regression coefficient b=0.38, 95% confidence interval 0.21,0.56), mothers and sons (b=0.47, 
95% CI 0.24,0.70), fathers and daughters (b=0.32, 95% CI 0.13,0,51), and mothers and 
daughters (b=0.39, 95% CI 0.15,0.63). For LDL cholesterol and apolipoprotein B similar 
associations were observed. The strongest associations were found for apolipoprotein Al 
between fathers and offspring and in particular sons (b=0.65, 95% CI 0.50,0.80), mothers and 
sons (b=0.78, 95% CI 0.60,0.95) and mothers and daughters (b=0.57, 95% CI 0.37,0.76). 
Apolipoprotein A I also showed the strongest association between levels in sons and daughters 
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Table 3.1. Characterist:ics of CAD+ and CAD- fathers and mothers and offspring. 
Variable Fathers Mothers Sons Daughters 
CAD+ CAD- CAD+ CAD- CAD+ CAD- CAD+ CAD-
(n"'90) (n952) (n"'9l) (n95l) (n=lIS) (n958) (n=73) (-7) 
Age (yrs) 56.4 ± 7.6 522 ± 8.1 t 52.5 ± 9.4 492 ± 7.9 * 25.5 ± 6.4 22.5 ± 5.6 t 25.4 ± 83 21.4 ± 7.7 t 
Height (em) 175.6 ± 6.0 178.6 ± 7.9 * 1663 ± 6.1 1662 ± 6.4 180.8 ± 9.7 1813 ± 11.3 167.0 ± 7.5 167.6 ± 9.9 
Weight (kg) 78.5 ± 8.7 79.8 ± 11.0 72.4 ± 12.5 71.4 ± 103 75.8 ± 12.9 73.8 ± 13.3 63.7 ± lI.5 60.1 ± 14.0 
Quetelet-index (kglm') 25.4 ± 2.2 25.0 ± 2.9 262 ± 4.5 25.9 ± 3.9 23.0 ± 2.9 22.3 ± 3.1 22.9 ± 4.0 212 ± 3.8 * 
... 
SBP(mmHg) 127.2 ± 12.8 127.5 ± 16.9 127.0 ± 16.7 125.3 ± 14.8 122.9 ± 13.4 1182 ± 14.5* 113.5 ± 14.5 1\6.0 ± 11.2 
'1' DBP (mmHg) 84.1 ± 11.1 82.1 ± 10.3 83.6± 11.1 81.0 ± 8.3 79.4 ± 10.1 73.9 ± 12.7t 74.3 ± !I.O 72.5 ± 8.4 
Smoking (%) 18.9 21.0 18.7 36.1 * 33.9 29.4 37.0 19.1 * 
Alcohol intllke (gIday) 13.8 ± 13.6 14.1 ± 11.4 6.4 ± 7.7 6.7 ± 8.0 11.6 ± 12.9 93 ± 9.6 4.8 ± 6.0 5.6 ± 6.4 
Coffee drinking (%) 98.9 93.5 97.8 98.4 82.6 73.5 753 5L1 t 
Post menarche (%) 92.8 84.1 
Pregnant at 2.9 7.1 
examination (%) 
Use of oral 435 452 
contraceptives (%) 
Values are means ± SD, unless stated otherwise. SBP = systolic blood pressure, DBP = diastolic blood pressure. Q 
-5 
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Table 3.2. Lipoproteins and apolipoproteins of CAD+ and CAD· fathers and the respective mothers in both 
groups, 
Variable Fathers Mothers 
CAD+ CAD· CAD+ CAD· 
(n~O) (n~2) (n~l) (n~61) 
Total cholesterol (mmolll) 6.9 ± 0.11 6.3 ± 0.14 + 6.6 ± 0.2 6.6 ± 0.18 
LDL cholesterol (mmolll) 5.I±O.l1 4.5 ± 0.13 , 4.6 ± 0.15 4.8 ± 0.19 
HDL cholesterol (mOlolll) 1.1 ± 0.03 1.2 ± 0.04 • 1.4 ± 0.03 1.3 ± 0.03 
HDL2 cholesterol (mmolll) 0.2 ± 0.01 0.2 ± 0,02 0.4 ± 0.03 0.3 ± 0.02 
HDL) cholesterol (nmlolll) 0.9 ± 0.02 0.9 ± 0.02 1.1 ± 0.03 1.0 ± 0.02 
Triglycerides (mmolll) 2.09 ± 0.09 1.50 ± 0.12 t 1.48 ± 0.08 1.25 ± 0.06 • 
Apolipoprotein AI (mg/dl) 133.5 ± 2.5 135.6 ± 3.8 155.0 ± 3.5 145.2 ± 3.8 
Apolipoprotein A2 (mg/dl) 45.3 ± 0.8 46.6 ± 0.8 47.3 ± 0.7 47.1 ± 0.9 
Apollpoproteln B (mg/dl) 131.4 ± 3.3 110.2 ± 3.7 I 111.0 ± 3.6 106.0 ± 3.5 
Values are means ± SEM, adjusted for age, LDL :=: low density lipoprotein, HDL :=: high density lipoprotein, 
• '" p<O.05j ~ :=: p<O.OOI for differences between CAD+ and CAD·. 
(b~0.55, 95% CI 0.35,0.74). Between fathers and mothers associations were observed for 
HDL, cholesterol (b~0.25, 95% CI 0.12,0.39) and apolipoprotein Al (b~0.43, 95% CI 
0.32,0.55). Much weaker or no associations between family members were observed for the 
other lipoproteins. 
We have attempted to assess the effects of possible changes in lifestyle, possibly advised to 
fathers, which may have been passed on to the children. There were no differences between 
the two groups of sons with regard to changes in reported smoking behavior, alcohol intake 
and fat intake after their fathers had been first examined for cardiac complaints. However, 
since this first examination, 39% of daughters of CAD+ fathers reported to have diminished 
their fat intake, as opposed to 17% of daughters of CAD· fathers (Yates corrected X' 5.1, 
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Table 3.3, Lipoproteins and apolipoproteins of the offspring of CAD+ and CAD~ fathers. 
Variable Sons Daughters 
CAD+ CAD- CAD+ CAD-
(n~115) (n~8) (n=l7) (n~73) 
Total cholesterol (mmolll) 5.4 ± 0.11 5.0 ± 0.10 5.6 ± 0.14 5.0 ± 0.15 
LDL cholesterol (mmolll) 3.7 ± 0.11 3.3 ± 0.10 3.6 ± 0.14 3.1 ± 0.15 
HDL cholesterol (mmolll) 1.2 ± 0.02 1.2 ± 0.03 1.5 ± 0.04 1.5 ± 0.04 
HDLl cholesterol (mmol/l) 0.2 ± 0,01 0.2 ± 0.02 0.4 ± 0.03 0.4 ± 0.03 
HDLJ cholesterol (nmlOlIl) 0.9 ± 0.02 1.0 ± 0.02 1.1 ± 0.02 1.1 ± 0.03 
Triglycerides (mmolll) 1.16 ± 0.06 1.13 ± 0.Q7 1.14 ± 6.0 1.04 ± 8.0 
Apolipoproteln AI (mg/dl) 126.6 ± 2.5 123.8 ± 2.8 159.6 ± 3.7 151.6 ± 4.3 
Apolipoprotein A2 (mg/dl) 44.1 ± 0.6 47.5 ± 1.3 46.6 ± 1.0 48.0 ± 1.0 
Apolipoprotein B (mg/dl) 89.4 ± 2.5 83.9 ± 2.5 86.9 ± 2.6 77.8 ± 3.6 
Apollpoproteln AI/B 1.6 ± 0.04 1.5 ± 0.06 1.9 ± 0.Q7 2.1 ± 0.09 
Values are means ± SEM, adjusted for age, 
p~0.02). A repeated measures analysis was performed in which an adjustment was made for 
the offspring living either with their parents or on their own. This analysis showed lower 
levels of HDL, cholesterol (difference -2.6 mgldl, 95% CI -5.3,0.2) and apolipoprotein A2 
(-5.5 mgldl, 95% CI -8.4,-2.5) in sons of CAD+ fathers. Similar results were observed in 
daughters of CAD+ fathers who had lower levels of HDL, cholesterol (-4.5 mgldl, 95% CI 
-8.2,-0.9) and apolipoprotein A2 (-4.5 mgldl, 95% CI -8.3,-0.7). 
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Table 3.4. Differences in lipoproteins and apolipoproteins of the offspring of CAD+ and CAD· fathers. 
Variable Sons Daughters 
Adjusted for Difference 95 %C.I. Difference 95% C.I. 
Total cholesterol (nunoI/l) age 0.11 [-0.18, OAI) 0.19 [-0_29, 0_68) 
age/risk factors· 0.0005 [-0.31, 0.32) 0,28 [-0,22, 0,78) 
LDL cholesterol (mmoI/l) age 0,14 [-0,16,0.44) 0_16 [-0,34, 0,66) 
age/risk factors 0,09 [-0,23, 0.42) 0,24 [-0,26, 0,74) 
HDL cholesterol (nunoI/l) age -0,04 [-0,13, 0,05) -0,005 [-0.13, 0.12) 
age/risk factors -0,07 [-0,16,0,02) -0,04 [-0.15,0.06) 
HDL2 cholesterol (mmoI/l) age 0,02 [-O.oJ, 0,08) 0,05 [-O.oJ,0,14) 
age/ risk factors 0,005 [-0.05, 0,06) 0,06 [-0,01, 0.12) 
HDL) cholesterol (mmoI/l) age -0,07 [-0.13,-0,0005) -0,05 [-0.13,0,04) 
age/risk factors -0,09 [-0.16,-0,03) -0,07 [-0,15, 0,02) 
Trlglycerides (mmolll) age -0,03 [-0.22,0.16) 0,09 [-0,32,0,15) 
age/risk factors -0.11 [-0.32,0,09) 0.13 [-0.09, 0,36) 
Apolipoprotein Al (mg/dl) age 3,1 [-6,3,12.5) 10,6 [-2,0, 23,3) 
age/risk factors -2,8 [-11.7,6,1) 11.9 [-0,7, 24,6) 
Apolipoprotein A2 (mgldl) age -5.1 [-7,9,-2.3) -2,7 [-5,9, 0,6) 
age/risk factors -4.4 [-7,0,-1.9) -2,1 [-5.3, 1.2) 
Apolipoprotein B (mgldl) age 2,1 [-5,1,9,2) 5,7 [-4.5, 15,9) 
age/risk factors -0,6 [-7,9,6,7) 8,1 [-1.3, 17.5) 
Apolipoprotein AI/B age 0,07 [-0,09,0,22) -0,05 [-0.30,0,20) 
age/risk factors 0,007 [-0,14,0,16) -0,08 [-0,31,0.14) 
Values are mean differences (values offspring CAD+ fathers· values offspring CAD· fathers) as calculated with 
repeated measures analysis of variance; 95% C.I.= 95% confidence interval; LDL = low density lipoprotein, HDL 
= high density lipoprotein; • = adjusted for risk factors: height, weight, systolic blood pressure, diastolic blood 
pressure, smoking, alcohol intake, and (daughters) use of oral contraceptives, 
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Discussion 
In this study we observed differences in lipoproteins and apolipoproteins between the 
offspring of fathers with and without coronary atherosclerosis. Sons and daughters of CAD+ 
fathers had a less favorable (apo)lipoprotein profile. Sons of patients with coronary artery 
disease had lower HDL, cholesterol and apolipoprotein A2 levels. Daughters of such patients 
tended to have lower levels of HDL, cholesterol and apolipoprotein A2 as well, but these 
differences reached only borderline significance. 
Before interpreting these findings some methodologic aspects of the study need to be 
discussed. We have assessed lipoprotein and apolipoprotein levels in young healthy adults in 
relation to coronary atherosclerosis in their parents. The selection of patients was based on 
coronary angiography, which enabled us to relate lipoprotein and apolipoprotein levels directly 
to risk of atherosclerosis. Coronary angiographic criteria were severe tluee-vessel disease in 
CAD+ fathers and virtually no coronary sclerosis in CAD- fathers in order to maximize the 
atherosclerotic contrast between these groups. This contrast is reflected in the differences 
found between the two groups of fathers with regard to lipoproteins and apolipoproteins, 
CAD+ fathers having a less favorable (apo)lipoprotein profile. 
Although there may be differences between the two groups of fathers with regard to lifestyle 
and medication, important differences, e.g. medication, will not be present in the offspring. 
A higher proportion of daughters of CAD+ fathers reported to have changed fat intake after 
their fathers had first been exanlined for cardiac complaints, but this was not accompanied by 
a change in other aspects of lifestyle, in particular smoking. Thus, the possibility that 
differential group changes of lifestyle could explain group differences in lipoproteins and 
apolipoproteins, cannot be completely ruled out. However, as it is not likely that changes to 
healthier lifestyles affect lipoprotein levels unfavorably, tlllS, if present, results in an 
underestimation of the true differences. Support for this was found in the analysis in which 
we adjusted for possible differences between offspring living with or separately from their 
parents. The latter group is supposedly less affected by lifestyle advise given to the fathers. 
This analysis did not materially change the results. 
The findings of the pres~nt study are generally in agreement with those in other studies (17) 
in that the offspring of patients suffering from coronary artery disease have less favorable 
lipid profiles. However, some studies have indicated that apolipoproteins, and particularly the 
ratio apolipoprotein Al/apolipoprotein B, measured in offspring of CAD patients are more 
strongly related to risk of cardiovascular disease than other (apo)lipoproteins (18-21). In the 
present study apolipoprotein B level and the ratio apolipoprotein Allapolipoprotein B were 
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not found to be significantly different between groups. Furthermore, in contrast to earlier 
studies, we found that HDL, cholesterol and apolipoprotein A2 levels in offspring of CAD+ 
fathers and particularly the sons of CAD+ fathers show important differences. Differences in 
results between earlier studies and the present study are that (apo)lipoproteins in offspring 
were studied in relation to myocardial infarction in the parents (19-21) and not specifically 
to atherosclerosis, which may reflect other mechanisms in addition to those leading to 
atherosclerosis. Another explanation for these differences may be that in the present study the 
offspring was older than in other studies (18-19). 
An inverse relation between HDL cholesterol and risk of ischemic heart disease is well 
established (22-25). HDL cholesterol has been shown to aggregate within families of patients 
with myocardial infarction (26,27) and, recently, HDL cholesterol subfractions and 
apolipoprotein Al as well as apolipoprotein A2 have been reported to be strongly and 
independently associated with risk of myocardial infarction (28,29). The results of the present 
study are in line with these studies and suggest that HDL cholesterol, its subfractions and 
related apolipoproteins playa role in atherogenesis early in life. The specific role that the 
HDL subfractions HDL, and HDL, play in the inverse relation with ischemic heart disease 
still has to be elucidated, although HDL, is thought to be the most important factor in this 
respect. In the present study total HDL cholesterol levels are somewhat lower in sons of 
CAD+ fathers and not materially different between the two groups of daughters, and HDL, 
cholesterol tends to be higher in both the sons and daughters of CAD+ fathers, which is 
suggestive of a shift from HDL, to HDL, cholesterol in sons and daughters of CAD+ fathers. 
In summary, we have compared lipoprotein and apolipoprotein levels in the offspring of 
patients suffering from severe, angiographically proven, coronary atherosclerosis with levels 
in offspring of patients with angiographically minimal coronary atherosclerosis. Lower levels 
of HDL, cholesterol and apolipoprotein A2 were found in the offspring and particularly in the 
sons of patients suffering from severe coronary atherosclerosis. Our findings add to the 
growing evidence that changes in lipoprotein and apolipoprotein levels can be detected 
relatively early in life. It is concluded that sons of patients with severe coronary sclerosis have 
reduced levels of HDL, cholesterol and apolipoprotein A2 and that these reduced levels may 
playa role in the development of coronary artery disease. 
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CHAPTER 4 
FAMILIES AND NATURAL HISTORY OF LIPIDS IN CHILDHOOD: 
AN 18 YEAR FOLLOW-UP STUDY 
Abstract 
4. Families and Natural History of Lipids in Childhood: 
an 18 year Follow-up Study 
Parental levels of total cholesterol were related to repeated measurements of total cholesterol 
and lipoprotein-cholesterol in their offspring in the EPOZ study. In the EPOZ study (1975 -
1978) risk indicators for chronic diseases were studied in families of which the members were 
5 years and over who were living in two districts in the Dutch town of Zoetermeer. A sample 
of youngsters was subsequently followed up for 18 years (average follow-up: 13.8 years) with 
yearly measurements of cardiovascular risk factors. Positive associations were found between 
age-adjusted tertiles of parental cholesterol levels and offspring cholesterol and low density 
lipoprotein-cholesterol levels, which persisted tlll'oughout childhood and young adulthood. 
Offspring with both parents in the upper cholesterol tertile had almost I nl1'll01l1 higher 
cholesterol levels compared to offspring with both parents in the lowest tertile. Differences 
between offspring of parents with high total cholesterol levels and parents with low levels 
were stable with increasing age of the offspring. There was considerable change with age of 
offspring cholesterol levels, with a dip around puberty. For high density lipoprotein-
cholesterol and its subfractions no relations with parental cholesterol level were found. 
In tllis study the aim was to assess parental cholesterol level as a determinant of offspring 
lipid level and change in lipid level over time. A strong positive association was shown 
between parental cholesterol levels and offspring cholesterol and low density lipoprotein-
cholesterol levels. This association was already detectable at a young age and persisted with 
increasing age. 
Introduction 
The natural history of lipids and lipoproteins in children and adolescents (1-5) suggests that 
serum lipids and lipoproteins show tracking from childhood into young adulthood, with lipid 
and lipoprotein levels remaining at relatively stable ranks within distributions over time. Thus, 
lipid and lipoprotein levels measured at a young age may be predictive of adult levels. 
Furthermore, in a recent prospective study (6), total cholesterol levels in young men were 
shown to be related to coronary heart disease much later in life. Preventive measures might 
therefore already be taken in childhood and adolescence. Lipids and lipoproteins tend to 
-56-
Chapter 4 
aggregate within families (7) and selective cholesterol screening may, among other indications, 
be recommended for children having a parent with a high blood cholesterol level (8). 
Therefore, it is important to know if offspring of parents with high risk factor levels have 
high levels themselves and to what extent these high levels persist throughout childhood and 
young adulthood. 
In this study the aim is to assess the relation between parental cholesterol level and offspring 
lipid levels and change in offspring lipid levels with increasing age. 
Methods 
Subjects 
All residents of ages 5 years and over who were living in two districts in the Dutch town 
of Zoetermeer were invited to participate in a study of risk indicators for chronic diseases 
(Dutch acronym: EPOZ study) (9-11). Zoetermeer is a suburban residential community near 
The Hague in The Netherlands, of at that time about 55,000 inhabitants. Between 1975 and 
1979, 4,649 persons aged 5 - 19 years took part in the study (82% of those invited). In 1980 
and 1981 all migrants moving to Zoetermeer were also asked to participate in the study. From 
this total group a random sample of 596 children was selected for annual follow up in a study 
of cardiovascular risk factors and its determinants. This paper deals with 483 subjects (81 %), 
252 males and 231 females, who took part in the follow up study. The average follow-up 
period was 13.8 years (range 3 to 18 years). Data on parents of these 483 subjects were 
obtained at the baseline study (1975 - 1981). Complete data were available for 425 fathers and 
454 mothers. In 1991, 352 subjects still took part in the follow up study. 
Measurements 
Both parents and offspring were seen at baseline (1975 - 1981). Subsequently, the offspring 
were seen yearly and measurements were performed by one research assistant throughout the 
whole follow-up period. At each examination systolic blood pressure (SBP) and diastolic 
blood pressure (DBP) were measured using a random zero sphygmomanometer (Hawksley) 
as described in detail elsewhere (12). Serum blood samples were drawn by antecubital 
venipuncture for measurement of total cholesterol, low density lipoprotein-cholesterol, high 
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density lipoprotein-cholesterol, and its subfractions high density lipoprotein2-cholesterol and 
high density lipoprotein3-cholesterol. Height and weight were measured without shoes and 
heavy clothing. At each examination, the offspring answered a questionnaire about use of 
medication, alcohol intake, coffee consumption and smoking habits. Additionally, daughters 
were asked about use of oral contraceptives, menstrual cycle and pregnancies. 
Laboratory analysis 
Serum total cholesterol at baseline was measured with an automated enzymatic method (13). 
During follow-up a modified reagent was used (CHODIP AP High Performance, Boehringer 
Mannheim, Germany). In the transition period both reagents have been used simultaneously, 
obtaining an excellent correlation (r>0.99). The overall coefficient of variation was 2.5% at 
baseline and 2.3% during follow-up. Cholesterol determinations at follow-up were performed 
on serum samples stored at -20'C for up to 4 years. Repeated measurements performed by our 
laboratory in frozen serum showed no significant changes up to 4 years after sampling 
compared to frozen samples measured within one week after venipuncture. The standard 
deviation of these duplicate measurements did not exceed 3.0% in all instances and did not 
show a significant drift. 
High density lipoprotein-cholesterol measurements were started in 1979 and low density 
lipoprotein-cholesterol measurements in 1984. High density and low density lipoprotein-
cholesterol were measured by the same method after precipitation. For high density 
lipoprotein-cholesterol the phosphotungstate method according to Burstein (14), with a minor 
modification as described by Grove (15) was used. For low density lipoprotein-cholesterol 
precipitation was carried out with polyvinylsulphate (Boehringer Mannheim, FRG). All 
measurements were carried out in the laboratory of the Department of Epidemiology & 
Biostatistics (Erasmus University Medical School), which participates since 1978 in the lipid 
standardization program of the WHO Regional Lipid Reference Centre in Prague (Dr. D. 
Grafnetler) and from 1979 in the Dutch National Cholesterol standardization program (KCA 
foundation), initiated in analogy to the program of the CDC Lipid Standardization Laboratory 
in Atlanta. In addition, during the baseline period quality control was indirectly checked on 
the CDC protocol by monthly comparison with cholesterol determination using the Abell-
Kendall method (Gaubius Institute TNO, Leiden). Both accuracy and precision of total and 
high density lipoprotein-cholesterol measurements were within acceptable limits (CDCfWHO) 
over the whole period. All automated analyses were initially carried out on a Technicon Auto 
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Analyzer-II system (Technicon Instruments, Tarrytown, USA) and from 1989 on a Kone 
Specific Analyzer (Kone Instruments, Espoo, Finland) using frozen (-20'C) serum samples. 
From 1987 high density lipoproteiu2 and high density lipoprotein3-cholesterol subfractions 
in serum were assayed as described by Gidez et al. (16) with slight modifications. High 
density lipoprotein2 and high density lipoprotein3-cholesterol subfractions were separated 
using stepwize precipitation of apolipoprotein B containing lipoproteins with heparinJMn" in 
two steps and high density lipoproteiu2 with dextran-sulphate. 
Data analysis 
The data analysis aimed to assess parental total cholesterol level as a determinant of 
offspring lipid level, and change in offspring lipid level over time. Mean values and standard 
deviations of baseline characteristics of parents and offspring were calculated. Tertile cut off 
values of the age-adjusted serum total cholesterol distributions were obtained for fathers and 
mothers separately. Baseline characteristics of sons and daughters were calculated according 
to both paternal and maternal tertiles of total cholesterol. In the offspring mean individual 
cholesterol and lipoprotein levels in 5 year age intervals were obtained by averaging for each 
subject all yearly measurements witllin that category. Thus, values from individual subjects 
could contribute to different age categories. Subsequently, mean total cholesterol and 
lipoprotein values were calculated according to tertiles of parental total cholesterol level. 
Offspring cholesterol levels were analyzed according to total cholesterol levels in fathers and 
mothers separately as well the combination of their total cholesterol levels, where both the 
father and the mother were in the same gender-specific tertile of their respective total senun 
cholesterol distributions. For testing group differences the lowest parental tertile values are 
taken as a reference category. 
Individual lipid level change with age was determined by calculating slopes of regression 
lines through total cholesterol and lipoprotein values in each of the above mentioned 5 year 
intervals. Again, subjects could contribute to values calculated for different age-categories. 
Differences in change of offspring lipid levels between parental tertiles were tested using 
Student's t-test with values in the lowest parental tertile as reference category. Group 
comparisons of changes in offspring lipid levels were weighed for the individual number of 
lipid measurements within age-categories. 
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Results 
Table 4. J shows antropometric characteristics, systolic and diastolic blood pressure and 
serum total cholesterol levels of fathers (n=l25) and mothers (n=454). Mean levels are also 
given by tertiles of parental total cholesterol levels. The cutoff-points of parental total 
cholesterol corresponding to the tertiles were 5.4 nunolll and 6.2 nnuoUI in fathers and 5.2 
nUnol/l and 6.0 mmol/l in mothers. In both fathers and mothers, Quetelet-index, and systolic 
and diastolic blood pressure were higher in those with higher total cholesterol levels. During 
follow-up, familial hypercholesterolemia was diagnosed in one mother and both her sons 
taking part in the present investigation. One of the sons started taking symvastatine in 1990 
and his later follow-up data were excluded from the analysis. 
Baseline characteristics of sons and daughters are shown in table 4.2, according to paternal 
tertiles of total cholesterol. Table 4.3 shows the same characteristics by maternal tertiles of 
total cholesterol. None of the differences between parental tertiles in table 4.2 and table 4.3 
was statistically significant. 
In table 4.4 total cholesterol and low density lipoprotein-cholesterol levels in offspring are 
shown by parental tertiles of serum total cholesterol levels. Thus, total cholesterol levels in 
offspring are given according to level in the father, irrespective of the total cholesterol level 
in the mother and vice versa. Total cholesterol and low density lipoprotein-cholesterol levels 
in children were strongly related to total cholesterol levels in their parents. For total 
cholesterol levels statistically significant differences were present between the highest and the 
lowest tertile. The differences persisted in the same direction in all age-categories but the last, 
while values in the medium tertile were consistently intermediate between values according 
to the lowest and the highest tertile. Differences between offspring total cholesterol levels by 
parental tertiles were fairly constant with increasing offspring age. In all tertiles the lowest 
offspring cholesterol levels were found in the age groups of 10 - 14 years and 15 - 19 years, 
suggesting a dip in cholesterol levels around puberty. Data according to paternal and maternal 
tertiles of total cholesterol are essentially similar, although the differences between mean 
offspring cholesterol levels by maternal tertiles seemed slightly larger than differences by 
paternal tertiles, amounting to more than 0.5 nnuoUI between the highest and lowest tertiles. 
The differences between tertiles were already present for the youngest age category and 
persisted into adult age-categories. Statistically significant differences in low density 
lipoprotein-cholesterol levels were found between the highest and lowest paternal tertile in the 
age categories from 15 to 29 years. Numbers on low density lipoprotein cholesterol 
measurements in the younger age categories (5 - 9 and 10 - 14 yrs) were too 
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Table 4.1. CbaracteriStics of fathers and mothers, who took part in the study (1975 - 1981): overall and by age-adjusted tertiles of total cholesterol. 
Fathers Mothers 
Overall Tertiles total cholesterol Overall Tertiles total cholesterol 
Low Medimn High Low Medium High 
Number of participants 425 142 141 142 454 150 152 152 
Age (yrs) 443 ± 79 44.6 ± 82 44.0 ± 7.7 44.4 ± 72. 415 ± 75 40.6 ± 69 42.1 ± 79 41.8 ± 7.6 
Height (em) 176.1 ± 7.0 176.8 ± 7.0 176.1 ± 7.1 1752 ± 6.8 1645 ± 6.1 1645 ± 6.0 164.4 ± 62 164.6 ± 6.1 
Weight (kg) 76.4 ± 102 749 ± 10.4 763 ± 10.8 77.9 ± 93 65.6 ± 102 62.8 ± 82 65.7 ± 10.5 682 ± 10.9 
Quetelet-index (kgfm'l 24.6 ± 2.8 24.0 ± 3.1 24.5 ± 2.7 25.4 ± 2.5 242± 35 232 ± 2.9 24.3 ± 3.6 252 ± 3.7 
Systolic blood pressure 128.2 ± 153 1252 ± 14.4 1282 ± 15.5 131.4 ± 15.3 1252 ± 16.7 120.5 ± 15.6 126.4 ± 16.6 128.8 ± 16.7 
(mmHg) 
Diastolic blood pressure 792 ± 11.1 77.6 ± 10.4 78.8 ± 11.1 81.3 ± 11.4 792 ± 12.0 75.5 ± 9.8 803 ± 12.2 81.7 ± 12.8 
(mmHg) 
Total cholesterol 5.9 ± 1.14 4.8 ± 0.5 5.8 ± 02 7.1 ± 0.9 5.7 ± 1.37 4.6 ± 0.5 5.6 ± 02 6.9 ± 1.6 
(mmol/l) 
range range range range range range 
3.4 - 5.4 5.4 - 62 62 - 10.0 2.5 - 52 52 - 6.0 6.0 - 24.1 
Values are mean ± SD. 
Q 
-5 
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Table 4.2. Baseline characteristics of SODS and daughters by tertiles of age-adjusted serum total cholesterol of fathers. 
Sons Daughters 
Tertiles total cholesterol fathers Tertiles total cholesterol fathers 
Low Medium High Low Medium High 
Number of participants 68 75 80 74 66 62 
Age (yrs) 13.6 ± 0.46 13.1 .:!: 0.49 12.9 ± 0.50 12.5 ± 0.44 13.1 ± 0.50 13.0 ± 0.56 
'" 
Height (em) 159.7 ± 233 156.5 ± 2.73 156.5 ± 2.63 151.2 ± 1.93 152.0 ± 2.26 150.2 ± 2.18 
~ Weight (kg) 47.3 ± 195 45.7 ± 2.08 459 ± 2.17 43.4 ± 1.50 43.6 ± 1.88 43.1 ± 1.87 
Quetelet-index (kglm') 17.8 ± 0.29 17.5 ± 0.28 17.8 ± 034 17.9 ± 030 18.0 ± 038 18.2 ± 038 
SystOlic blood pressure (mmHg) 103.9 ± 1.45 1033 ± 1.50 103.4 ± 1.57 98.5 ± 1.06 97.8 ± 1.28 97.8 ± 138 
Diastolic blood pressure (mmHg) 58.0 ± 096 55.4 ± 098 57.0 ± 092 563 ±092 55.6 ± 0.81 56.0 ± 1.07 
Ever smoked (%) 22.4 26.4 23.8 24.8 223 20.3 
Current smoking (%) 16.7 20.0 20.5 21.2 20.1 21.2 
Use of oral contraceptives (%) 273 23.7 20.1 
Values are mean ± SEM. 
Q 
.§ 
~ 
... 
Table 4.3. Baseline characteristics of sons and daughters by tertiles of age-adjusted serum total cholesterol of mothers. 
Sons Daughters 
Tertiles total cholesterol mothers TertiIes total cholesterol mothers 
Low Medium High Low Medium High 
Number of participants 81 68 84 69 84 68 
Age (yrs) 132 ± 0.48 132 ± 0.52 132 ± 0.46 122 ± 0.48 132 ± 0.45 12.7 ± 0.50 
'" 
Height (em) 158.2 ± 237 1572 ± 2.59 156.5 ± 2.61 149.5 ± 1.99 153.5 ± 2.01 1503 ± 2.13 
'f Weight (kg) 46.7 ± 1.91 463 ± 2.19 46.9 ± 2.05 40.7 ± 1.65 44.6 ± 1.64 42.9 ± 1.74 
Quete1et-index (kglm'l 17.7 ± 0.29 17.8 ± 034 18.0 ± 028 17.4 ± 032 18.1 ± 0.34 182 ± 036 
Systolic blood pressure (mmHg) 103.9 ± 1.43 104.6 ± 1.61 104.1 ± 1.40 98.5 ± 1.16 97.5 ± 1.13 98.6 ± 121 
Diastolic blood pressure (mmHg) 56.6 ± 1.01 57.4 ± 1.02 56.9 ± 0.82 54.7 ± 0.92 563 ± 0.83 55.9 ± 0.94 
Ever smoked (%) 20.6 21.0 24.0 24.0 23.1 21.7 
Current smoking (%) 19.6 192 18.7 212 21.7 212 
Use of oral contraceptives r/o) 24.5 25.5 20.8 
Values are mean ± SEM 
Q 
~ 
~ 
.... 
Table 4.4. Total cholesterol and LDL cholesterol in offspring by tertiles of total cholesterol in fathers and in mothers. 
Tertiles of total cholesterol in fathers Tertiles of total cholesterol in mothers 
A$e Low Medium High Low Medium High 
5-9 4.6 ± 0.06 4.6 ± 0.1 5.0 ± 0.09 • 4.6 ± 0.06 4.8 ± 0.10 4.9 ± 0.09 .. 
10 - 14 4.5 ± 0.07 4.7 ± 0.07 * 4.8 ± 0.Q7 t 4.6 ± 0.08 4.7 ± 0.06 .. 4.9 ± O.Q71O 
Total cholesterol 15 - 19 4.5 ± 0.Q7 4.7 ± 0.06 * 4.8 ± 0.06 t 4.4 ± 0.06 4.6 ± 0.05 * 4.9 ± O.Q71O 
'" 
(mmol/l) 20 - 24 4.9 ± 0.08 5.0 ± 0.Q7 52 ± 0.07 t 4.8 ± 0.06 5.0 ± 0.06 t 53 ±0.081O f'-
25 - 29 5.1 ± 0.09 5.4 ± 0.09 * 5.5 ± 0.09 t 5.0 ± 0.Q7 5.4 ± 0.09 t 5.6 ± 0.10 • 
30 - 37 52 ± 0.17 53 ± 0.11 5.6 ± 0.14 5.1 ± 0.14 55 ± 0.14 * 5.6 ± 0.16 .. 
15 - 19 2.7 ± 0.12 3.0 ± 0.15 3.0 ± 0.10 * 2.8 ± 0.12 2.9 ± 0.09 3.1 ± 0.14 * 
LDL cholesterol 20 - 24 3.0 ± 0.09 33 ± 0.11 * 3.4 ± 0.09 t 2.9 ± 0.08 32 ± 0.08" 3.6 ± 0.11 1: 
(mmol/l) 25 - 29 32 ± 0.11 3.5 ± 0.10 3.7 ± 0.10 t 3.1 ± 0.09 35 ± 0.10 * 3.7 ± 0.11 1: 
30 - 37 3.4 ± 0.18 3.4 ± 0.11 3.4 ± 0.16 33 ± 0.14 3.6 ± 0.15 3.7 ± 0.16 • 
Values are mean ± SEM. LDL = low density lipoprotein; * = p<o.05, t = p<o.OI. ::: = p<O.OOl, reference category: lowest parental tertile. 
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small to allow a meaningful analysis. The direction and magnitude of the differences found 
for low density lipoprotein-cholesterol levels were quite similar to those found in total 
cholesterol levels and again differences according to maternal tertiles were higher than 
according to paternal tertiles. 
High dens;ty lipoprotein-cholesterol, high density lipoprotein2-cholesterol and high density 
lipoprotein3-cholesterollevels did not show differences by paternal and maternal tertiles nor 
were they detectable with increasing age, Pooled levels (over age) for males were: high 
density lipoprotein-cholesterol 1.2 ± 0.01 mmoUI (mean ± SEM); high density lipoprotein2-
cholesterol 0.26 ± 0.010 mmoUI and high density lipoprotein3-cholesterol 0.90 ± 0.008 
IllIllOUI. Pooled values (over age) for females were 1.4 ± 0.02 ImnoUI; 0.44 ± 0.014 lllIlloUI 
and 0.98 ± 0.011 lllIlloUI respectively. 
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Figure 4,1. Total cholesterol in daughters and sons by tertiles of total cholesterol in mothers and fathers. 
'" = p<O,05, t = p<Q,Ol, t = p<O,QOI, with lowest tertile as reference category, 
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Figure 4.1 shows total cholesterol levels separately in daughters and sons by paternal and 
maternal tertiles of total cholesterol. There were no major differences between the gender 
specific data and the overall analyses. However, in sons the data were suggestive of u steeper 
rise in total cholesterol levels after age 15 in both paternal and maternal tertiles. 
In figure 4.2 serum total cholesterol levels in offspring are shown according to tertiles of 
total cholesterol in the fathers (upper left), the mothers (upper right), and both 
Total ehole5terolln of tip ring by lertile5 of tolal chotesltrol (alhers 
(3~llmavin8IWngtl) 
, 
t .... ~.- -~ .. ~ ... : .. : 
............. 
" " .. :: .. ' ....... 
- I'lthellnh1sh~lurti!e 
- - - Father In m~.jiom Utblt 
F'~llnkwtJllutile "*IO~~~'1S~~~'''~~~-,''~~~-,lO 
Ag~(yean) 
Total cholesterol in offspring by lertilt.!l of tolal cholesterol parents 
(1 YUI mavinglVtllgU) 
---
'-r----t --, .... _--" ................... 
... ~ ... 
- Bo-thpmntllnblghtolkrlile 
- - - Bothpmnll!<lm«llutllUrtiIc 
-- Bothpll.!IIll.!!t~llcrtile "+IO'-"'-IT,.-~.-,,~~~~,,~~~~lO 
Age (rl:m) 
Total cholesterol In offspring by tertiles of total cholesterol mothers 
(lyur mMg Ivuagtl) 
- Mothtf In hl$.he.llertile 
- - - MOIhu In oxdlUlIl tertile 
Mother In t<:rwe&lutb1e "+,~.-TO~~~.-"~~~~~~ 
ro " ~ ~ W 
Age (yean) 
Figure 4.2. Serum total cholesterol levels in offspring according to tertlles oftolal cholesterol levels in fathers 
(upper left), mothers (upper right), and both parents (lower). 
fathers and mothers (lower panel). When offspring was analyzed that had both fathers and 
mothers in the same gender specific tertile the offspring differences between parental tertiles 
increased to almost I mmoUI between the lowest and highest tertile. Again, total cholesterol 
levels dipped between 15 and 20 years of age, most clearly for the lowest two tertiles and 
showed a gradual increase thereafter. 
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Figure 4.3. Change of tolal cholesterol level in offspring by tertiles of palemal (upper panel) and matemal 
(lower panel) tolal cholesterol. Bars represent mean 5-year change. 
Figure 4,3 show., the age-specific change in total cholesterol in offspring by paternal tertiles 
(upper panel) and maternal (lower panel) tertiles of total cholesteroL It shows that in each 
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tertile there is a decrease of total cholesterol levels up to age 15 and a rise in total cholesterol 
levels from age 15 to 25. None of the differences in change between parental tertiles was 
statistically significant. 
Before 1991, there were 131 offspring who terminated their participation in the study. 
Separate analyses were performed to evaluate if this group of offspring was differentially 
distributed over parental groups. In the fathers there were 44 offspring from the low group 
who terminated participation, 35 offspring from the medinm group and 33 from the high 
group. These offspring groups showed differences in total cholesterol levels by parental 
tertiles for the 5 year age groups which were similar to those found for still participating 
subjects. In the age category 15 - 19 years the low paternal group (n=41) had mean total 
cholesterol levels of 4.4 ± 0.11 mmoUI, the medium group (n~26): 4.6 ± 0.12 mmoUI, and 
the high group (n~26): 4.9 ± 0.15 mmoUI. Similar differences were found when analyzed 
according to maternal level. 
Discussion 
In the present study, we have found a strong positive relation between parental levels of 
serum total cholesterol and levels of serum total cholesterol and low density lipoprotein-
cholesterol levels in their offspring. Offspring group differences in total cholesterol and low 
density lipoprotein-cholesterol were present from childhood and persisted into young 
adulthood, while throughout this period these group differences remained rather constant. No 
associations between parental total cholesterol levels and offspring high density lipoprotein-
cholesterol and its subfractions were found. The association between maternal total cholesterol 
levels and offspring total and low density lipoprotein-cholesterol levels appeared slightly more 
pronounced than for paternal total cholesterol levels. The largest effects were observed when 
cholesterol levels of both parents were taken into account. The association for daughters and 
sons did not differ materially. 
Before we can interpret these findings some methodological aspects of the study have to be 
discussed. The present analyses are based on data obtained in a random sample of youngsters 
initially examined in a population survey and subsequently invited for longitudinal follow-up. 
It is felt that response rates were high enough to consider this sample representative of the 
source population. Loss-to-follow-up would have biased our results if offspring loss-to-
follow-up would be differentially (with regard to offspring groups) associated with risk factor 
levels. However, there was no evidence from the data for such differentialloss-to-follow-up. 
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During the whole follow-up period laboratory measurements quality was controlled by the 
CDCfWHO (total cholesterol and high density lipoprotein-cholesterol) and by KCA (for total 
cholesterol measurements) and no drift of measurements over time was observed. 
Coronary heart disease tends to aggregate in families (17-19). In two recent prospective 
studies it was shown that a parental history of myocardial infarction is an independent risk 
factor for coronary artery disease (20,21). A number of cross-sectional studies has shown that 
the offspring of patients with cardiovascular disease have less favorable (apo)lipoprotein 
profiles as compared to offspring of non-patients (22-25). This familial aggregation of 
coronary heart disease may reflect shared genetic factors, shared environmental factors, or 
both. Coronary heart disease risk factors themselves have also been shown to aggregate within 
families (7,26,27). The cross-sectional relation between total cholesterol levels in parents and 
offspring total cholesterol and lipoprotein-cholesterol levels throughout childhood and young 
adulthood has been reported earlier (28), including in the present cohort (29). Tracking of 
lipids at a young age has been demonstrated in a number of studies in general populations of 
children and young adults (1-5). In the present study the parent-offspring relation with regard 
to cholesterol and lipoprotein-cholesterol levels is further shown to persist longitudinally. This 
indicates that the influence of parental cholester levels on cholesterol levels in their offspring 
is apparent particularly at a young age and much less thereafter. In general, the origins of 
parent-offspring similarity may be genetic, acquired or both. Genetic explanations for familial 
similarity among relatives of adverse lipid levels are the genetic dyslipoproteinemias, of which 
the autosomal dominant disorders familial hypercholesterolemia, leading to impaired low 
density lipoprotein-receptor function and familial combined hyperlipidemia are the most 
frequent. Familial hypercholesterolemia was confirmed in one family taking part in the present 
study. The finding that there were no significant differences in change with increasing age of 
total cholesterol and low density lipoprotein-cholesterol levels between the groups of offspring 
suggests that parental cholesterol level, although strongly related to offspring level, is not a 
major determinant of change in offspring levels. TillS means that offspring group differences 
in total cholesterol and low density lipoprotein-cholesterol by parental levels of total 
cholesterol are not only found in cross-sectional analyses but also longitudinally. Thus, on an 
individual level, children of high risk parents have on average higher levels of the studied risk 
factors than children of low risk parents irrespectivem of their age. The phenomenon of 
familial aggregation of cardiovascular risk factors may underlie aggregation of coronary heart 
disease and it may further provide a tool for its prevention at an early age. 
In conclusion, our longitudinal data show a strong positive association between parental 
cholesterol levels and the levels of total and low density lipoprotein-cholesterol levels in their 
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offspring. 
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CHAPTER 5 
GENERAL DISCUSSION I 
5. General discussion I 
Introduction 
In the studies described in this thesis the focus is on etiology; lipids and lipoproteins as 
putative causal risk factors of atherosclerosis. Conunon to the definitions of causality in 
medical science is the notion that exposures antecede health outcomes. As atherosclerosis is 
a life-long process, a point of departure in the study of causality is to ensure that factors of 
interest do indeed antecede atherosclerosis. What are the suitable options in study design that 
meet this requirement? Let us examine the example of postprandial lipid metabolism and 
coronary artery disease. One option would be to measure postprandial lipids in a group of 
children and young adults and follow these subjects until manifest coronary artery disease 
occurs in some of them. This cohort design, although valid in itself, would obviously require 
a very long study period and large numbers of subjects and thus is rather impractical. Still, 
such a study has been performed for the classical cardiovascular risk factor serum total 
cholesterol in yOlmg men who were followed for 27 to 42 years (I). 
Alternatively, a study may be considered in which postprandial lipid metabolism is 
examined in groups of diseased and non-diseased subjects. In general, such a study carmot 
exclude the possibility that the process of atherosclerosis itself influenced postprandial lipid 
metabolism or that atherosclerotic events and symptoms change behavior, which in turn may 
influence postprandial lipid metabolism. There is one exception for which this design could 
be used and the time-sequence criterion could unequivocally be met. If, hypothetically, an 
unfavorable postprandial lipid metabolism was known to be completely genetically determined 
and would express at a young age, studying postprandial lipids in patients with coronary artery 
disease would lead to valid results, in the sense that the exposure, unfavorable postprandial 
lipid metabolism, precedes the outcome, coronary atherosclerosis, in time. However, as the 
genetic contribution and mechanistic pathways to postprandial lipids is not fully understood, 
such a study design will not inherently meet the time-sequence criterion. 
A valid and efficient alternative is provided by the patient-offspring study as described in 
chapters 1 and 2 of this thesis. In the patient-offspring study, risk factors are measured in 
offspring of patients with the disease and compared with risk factors measured in offspring 
of parents who do not have the disease. Tlus design allows to study the relation between a 
risk factor and disease, such as coronary atherosclerosis, where the risk factor is measured in 
the offspring who have not yet developed coronary atherosclerosis. In the next sections the 
essential characteristics of this design are discussed. 
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The patient-offspring study 
Design 
In general, a study in parents and their offspring may be used to assess the relation between: 
1. a risk factor (R) in offspring and the same factor in parents (R-R), or 
2. an outcome (D) in offspring and the same outcome in parents (D-D), or 
3. a risk factor in offspring and disease in parents: the patient-offspring study 
The underlying assumptions in these three types of study are familial aggregation of risk 
factors (R-R), of disease (D-D), or both. In the first type of study the assumption is similarity 
of risk factor levels in parents and their offspring, in other words familial aggregation of risk 
factor levels (R-R). In the second type of study it is expected to find more disease among 
offspring if in their parents the disease has occurred, in other words familiar aggregation of 
. disease (D-D). 
The third type of study will be referred to as the patient-offspring study. In the patient-
offspring study the goal is to study risk factors for a disease before the occurrence of the 
disease. The study design as described in chapters 1 and 2 of this thesis is depicted in figure 
5.1. In these studies, a group of fathers with coronary artery disease and a reference group of 
fathers without coronary artery disease was selected, irrespective of the disease status in the 
mothers. Levels of putative risk factors were compared between the sons of both groups of 
fathers. 
Premises 
1. Familial aggregation of risk factors 
One point of departure in a patient-offspring study is the assumption of familial aggregation 
of disease (D-D aggregation). In this paragraph we will examine how this relates to causes 
for disease in patients and offspring. 
In a multifactorial disease such as coronary artery disease we may distinguish familial risk 
factors and non-familial risk factors. The familial risk factors may be genetic factors or 
acquired factors that aggregate in families (R-R aggregation). Non-familial risk factors for 
-75-
Chapter 5 
coronary artery disease are not transmitted from one generation to another. The disease is 
Fathers Mothers Fathers Mothers 
CAD + CAD-
I I I I 
I I 
Offspring Offspring 
R R 
Figure 5.1. The patient-offspring study: a risk factor is studied in offspring of parents with and without coronary 
artery disease (CAD). 
caused by: a set of familial risk factors; or a set of non-familial risk factors; or combinations 
of familial and non-familial risk factors. Every patient with coronary artery disease has at least 
one of these three combinations of risk factors. 
In an unselected group of patients with coronary artery disease, some patients will have 
familial and non-familial risk factors, other patients will have familial risk factors only and 
yet other patients will only have non-familial risk factors. Suppose that we now follow a 
group of healthy offspring of patients with coronary artery disease from the present into the 
future and select those who developed coronary artery disease. These offspring will not 
necessa'ily have the same distribution of causes for coronary artery disease as the total group 
of diseased parents. In these offspring we will particularly find familial risk factors, perhaps 
in combination with non-familial risk factors. In some of the offspring with coronary artery 
disease we will find sets of non-familial risk factors only. A smaller proportion of the 
offspring of controls, as compared to offspring of cases, will also develop coronary artery 
disease in the future. However, because they have healthy parents, familial risk factors, 
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exclusively or in combination with non-familial risk factors, will be found less frequent in 
these diseased offspring of controls than in the diseased offspring of patients. In the diseased 
offspring of controls a much larger proportion of disease will be due to sets of non-familial 
risk factors. If the familial and non-familial risk factors are not correlated, the percentage of 
the nnselecte~ offspring of controls with non-familial risk factors only will be similar to the 
percentage of the unselected offspring of cases with non-familial risk factors only. Therefore, 
in offspring of patients we will find the familial risk factors to be different from those in 
offspring of controls. The non-familial risk factors may be found in both groups of offspring, 
but none of these will be differently distributed in offspring of cases compared with controls. 
TillS example shows that the patient-offspring study can only detect differences between 
offspring groups in risk factors that are familial and not in risk factors that are non-familial. 
Familial aggregation of the disease thus is not sufficient as a basis for the patient-offspring 
study, the premise is familial aggregation of risk factors. 
2. Tracking by parental risk 
Given that a risk factor is fanlilial, the patient-offspring study aims to detect differences in 
risk factor levels between offspring of patients and offspring of controls. It would facilitate 
the patient-offspring study if these risk factor differences between offspring groups can be 
detected in a large age range of the offspring. This requires that the risk factor levels are 
higher in offspring of patients than in offspring of controls over long periods of time. The 
group differences may change in magnitude but should remain over time. The examination 
of such 'tracking by parental risk' requires a study as described in chapter 4 of this thesis, 
which evaluated whether offspring of high risk parents (based on high cholesterol levels) have 
high cholesterol levels over time. Risk factors that do not track by parental risk are much 
more difficult to detect in a patient-offspring study. 
Quant!fication of the effect 
In each of the tluee types of study relating characteristics in parents to characteristics in 
their offspring, the parent to offspring transmission has to be considered. In the patient-
offspring study, given that the disease is multifactorial, the risk factor under studY'will 
probably explain only part, if any, of the occurrence of the disease. The subgroup of parents 
with the risk factor will transmit it to a proportion but not to all of their offspring. In the 
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hypothetical situation of a purely Mendelian inheritance of a risk factor the expected 
proportion of offspring with the risk factor can be calculated and is it possible to infer the 
strength of the Ime risk factor-disease association (2). Also, if the risk factor were completely 
acquired it seems unlikely that an environment that has led to high levels of the risk factor 
in the parents will in all instances lead to similarly high levels in their offspring. 
Consequently, if in the patient-offspring study a relation is found between a risk factor in 
offspring and parental disease it will probably always underestimate the strenght of the 
OCcurrence relation that one would find in the patients themselves. In other words, the relation 
between offspring risk factor levels and parental disease is likely to reflect a dilution or 
smaller derivative of the real occurrence relation. 
The extent to which a risk factor aggregates in families (R-R) is an indicator of the 
underestimation of the occurrence relation. Familial aggregation of disease (D-D) may be 
predominantly explained by other familial risk factors than the one under study. Thus, familial 
aggregation of the risk factor is more indicative of the magnitude of underestimation than 
familial aggregation of disease. 
Inference 
Except for ecological studies, risk factor and disease status in epidemiologic research are 
assessed in the sarne individuals. In the patient-offspring study, however, risk factors and 
disease are measured in different individuals; offspring and parents. In this type of study it 
is not immediately apparent what the conceptual unit of observation is. In most studies the 
increased risk for disease in offspring is taken as the starting point in lipid research (3-7) and, 
for instance, hypertension research (see for review 8). Thus, many investigators set out to 
relate offspring risk factor levels to increased offspring disease risk. Here, the offspring are 
taken as the conceptual units of observation and parental disease is taken as a proxy for 
disease in the offspring. This will be referred to as the offspring-perspective. This perspective 
is graphically depicted for atherosclerosis in figure 5.2. It shows the hypothetical situation 
where there is familial aggregation of atherosclerosis. In the patient-offspring study parents 
are selected according to their presence of coronary atherosclerosis and risk factors are 
measured in their offspring at some point in time (To). In the cases (upper panel), parents have 
high degrees of atherosclerosis. In the controls (lower panel), parents have low degrees of 
atherosclerosis. Based on D-D type aggregation, a proportion of the offspring of cases (upper 
panel) will at some point in their future develop atherosclerosis. Most of the control offspring 
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(lower panel) will maintain low degrees of atherosclerosis. Suppose that in the offspring-
perspective familial as well as nOll-familial risk factors are examined in relation to the proxy 
of disease. As shown earlier non-familial risk factors will not be different between offspring 
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Figure 5.2. Schematical representation ofthe offspring-perspective to a patient-offspring study. Risk factor levels 
are indicated by lines within bars. 
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groups even though they may be causally related to the disease. 
From the offspring-perspective, however, it is not uncommon that it will be concluded. th~t _ 
non-familial risk factors are not related to the disease, without considering the alternative 
explanation that such risk factors are not familial. An example of such a pitfall is presented 
in a landmark report on lipoproteins and apolipoproteins that was published in the New 
England Journal of Medicine by Freedman and colleagues (7). In this study on data from the 
Bogalusa Heart Study, the authors report on the assessment of lipoprotein-cholesterol levels 
and apolipoprotein A-I and B levels in children of fathers who rep0l1ed to have had a 
myocardial infarction as compared with children whose fathers did not report such a medical 
history. Logistic regression was used to predict on the basis of levels of offspring serum 
variables the probability of myocardial infarction in the parents. Because the authors stated 
that this study design may provide "relevant information concerning the future risk of 
disease", they presumably had the intent to use parental myocardial infarction as a proxy of 
offspring disease. No offspring differences were found for lipoprotein-cholesterol fractions. 
Adverse levels of apolipoproteins A-I and B were found in offspring of fathers with 
myocardial infarctions. It was concluded that apolipoproteins may be more strongly related 
to the risk of cardiovascular disease than lipoprotein-cholesterol fractions. However, 
apolipoproteins A-I and B could show different levels of familial aggregation than 
lipoprotein-cholesterol fractions. Apolipoprotein levels are probably more genetically 
determined than lipoprotein-cholesterol levels (9). Differences in familial aggregation between 
apolipoproteins and lipoprotein-chOlesterol fractions could provide an alternative explanation. 
The question is ifthere is a better approach to the patient-offspring study that will prevent this 
type of erroneous inference. 
We introduce the parent-perspective as a better approach to the patient-offspring study. In 
this approach, offspring levels of a risk factor are taken as a proxy for parental levels of this 
risk factor when they were of the age of their offspring. Parents are chosen as lmits of 
observations, an orientation that we will further refer to as the parent-perspective. The parent-
perspective to the patient-offspring study is graphically depicted in figure 5.3. The same 
patient-offspring study as depicted in figure 5.2 is performed at To. Now, however, estimates 
are made of parental risk factor levels in their past through offspring risk factor levels 
measured at To. These estimates are related to parental current disease, with the classical case 
control study as the paradigm. At To, the cases are parents with high degrees of atherosclerosis 
(upper panel). At To, the controls are parents with low levels of atherosclerosis. 
Atherosclerosis in both offspring of cases and of controls is still minimal. 
From the parent-perspective in the patient-offspring study only familial risk factors will be 
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studied. Non-familial risk factors will not be studied, because they are not a proxy for parental 
levels of these risk factors. Information about these non-familial risk factors must be obtained 
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Figure 5.3. Schematical representation of the parent-perspective to a patient-offspring study. Risk factor levels 
are indicated by lines within bars. 
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from other research. 
Thus, contrary to the offspring-perspective, the parent-perspective to the patient-offspring 
study inherently meets its prior premise, the familial aggregation of the risk factor under 
study. 
Consideration of familial aggregation of the risk factor is a logical step in the parent-
perspective which protects the investigator from the pitfalls of interpretation. Therefore, the 
parent-perspective provides a better orientation to the patient-offspring study than the 
offspring perspective. 
Summary 
The time-sequence of risk factors and subsequent disease occurrence is an important 
criterion for causality. In the patient-offspring study risk factor levels in offspring are related 
to disease in their parents and aim to meet the time-sequence criterion. It gives a valid and 
feasible tool for studying etiological relations between risk factors and a multifactorial disease. 
While in the patient-offspring study measurements of risk factors and disease take place at one 
point in time it can detect relationships between risk factors and disease that would otherwise 
require studies with long follow-up and large numbers of subjects for their assessment. 
In tllls chapter we discussed the premises for the patient-offspring study. It was shown that 
disease aggregation is not sufficient as a point of departure for the patient-offspring study. A 
first premise for the patient-offspring study is that there is familial aggregation of the risk 
factor (R-R). If tltis premise of fanlilial aggregation risk factor is not met, the absence of 
familial aggregation of a risk factor should be considered as an alternative explanation for a 
zero finding. A second premise is that there is 'tracking by parental risk' from young into late 
adulthood, which facilitates the possibility for a patient-offspring study to detect offspring 
group differences in risk factor levels. 
If there is familial aggregation of the risk factor it is not known to what extent risk factors 
are transmitted from one generation to the next generation. Therefore, the patient-offspring 
study will not provide exact information about the strengths of risk factor - disease 
associations. If risk factors differ in familial aggregation, they will differ with respect to the 
strenght of association with the disease. This sets limitations to conclusions from the patient-
offspring study about which of these risk factors is best suitable for intervention. 
The offspring-perspective to the patient-offspring study takes parental disease as a proxy for 
offspring future disease. Because the disease-proxy involves a selection of causes, in particular 
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causes involving familial risk factors alone or in combination with non~familial risk factors, 
this offspring-perspective may lead to wrong inference with respect to non-familial risk 
factors. The parent-perspective uses offspring risk factor levels as a proxy for parental risk 
factor levels in the past. Because in the parent-perspective it is a logical step to evaluate the 
premise of familial aggregation of the risk factor it is considered less vulnerable to erroneous 
interpretation of results. 
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CHAPTER 6 
GENERAL DISCUSSION II 
6. General discussion II 
In general discussion I essential aspects of the patient-offspring study were discussed in 
relation to familial aggregation of disease and familial aggregation of risk factors. In this 
chapter familial aggregation of cardiovascular disease and its risk factors will be discussed. 
Familial aggregation of cardiovascular disease and cardiovascular risk factors 
Heart attacks occur more often in certain families, an observation that dates back decades 
before the concept of coronary risk factors. Already in the 50's and 60's family history studies 
demonstrated that coronary heart disease aggregates in families (1-3), particularly when the 
proband had coronary heart disease at a relatively young age (3-5). Where cardiovascular 
disease runs in families, the same is true for classical risk factors for cardiovascular disease 
such as hypertension (6,7), smoking (8), and cholesterol levels as was also shown 
longitudinally in chapter 4 of this thesis. Other factors related to coronary artery disease 
including diabetes mellitus (9,10), obesity (II) and physical fitness (12) have been reported 
to aggregate in families as well. In cardiovascular research a question has been to what extent, 
if at all, familial aggregation of coronary heart disease may be attributed to familial 
aggregation of the known cardiovascular risk factors. In a number of prospective studies (13-
19), cardiovascular risk profiles were related to the occurrence of cardiovascular disease in 
subjects who had family relatives with cardiovascular disease and thus had a positive family 
history. Overall, these studies have indicated that familial aggregation of cardiovascular 
disease can only partially be attributed to classical cardiovascular risk factors. The question 
remains how this may be explained. It may be that members of families in which 
cardiovascular disease aggregates have an increased susceptibility to the effects of classical 
risk factors. Thus, this increased susceptibility may be an unknown risk factor in itself. 
Alternatively, the familial aggregation of cardiovascular disease may be related to other, as 
yet unknown, risk factors. Such new risk factors and their relation with fanlilial cardiovascular 
disease may be studied with the patient-offspring study. In chapters 2 and 3 the angiographic 
patient-offspring study was used to assess relatively unexplored risk factors such as changed 
postprandial lipoprotein metabolism and apolipoproteins. Familial aggregation of postprandial 
responses to an oral lipid load has, to our knowledge, not been studied. There are, however, 
some indications for familial aggregation of an increased triglyceride response to an oral lipid 
load in families of probands with coronary heart disease. Familial aggregation of lipids, 
cholesterol and its subfractions has been reported in several studies, including determinants 
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of postprandial lipid metabolism such as triglyceride level and high density lipoprotein-
cholesterol level (20-25). 
Tracking of risk factors 
The phenomenon of tracking of a risk factor for a disease concerns the stability of 
individual's ranks of the risk factor level within the distribution of this risk factor over time. 
In general discussion I it was pointed out that 'tracking by parental risk' is one of the 
premises for the patient-offspring study. 
A number of longitudinal studies in children and young adults has shown tracking for total 
cholesterol and low density lipoprotein cholesterol in childhood and young adulthood, with 
weaker levels of tracking for high density lipoprotein cholesterol and triglycerides (26-35). 
The apolipoproteins A-I and B were shown to track to a similar extent as high density 
lipoprotein cholesterol and low density lipoprotein cholesterol respectively (36). Recently, 3-
. year tracking was shown for high density lipoprotein, and to a lesser extent high density 
lipoprotein,-cholesterol (37), high density lipoprotein, being considered a determinant of 
postprandial triglyceride metabolism (38). Thus, there is a large body of evidence from 
popUlation studies that lipoproteins and apolipoproteins track over time. To our knowledge 
there have been no reports actually showing tracking of postprandial lipids and lipoproteins 
over time. Repeated measurements of postprandial triglyceride responses suggested some 
degree of stability of ranking, although these were performed in small numbers of subjects 
and over short time intervals (39,40). 
In the study of tracking by parental risk, categories are made of parental risk factor levels 
and the ranks of offspring risk factor levels are followed over time according to these parental 
categories. Parent-offspring similarity of total cholesterol values throughout childhood and 
early adulthood has been shown previously (23,41). The study in chapter 4 on the EPOZ 
popUlation describes the yearly follow-up of total cholesterol and lipoprotein-cholesterol levels 
in offspring according to tertiles of total cholesterol levels in their parents. It illustrates that 
total cholesterol and low density lipoprotein cholesterol values in offspring are related to 
parental levels of total cholesterol. There were clear differences between offspring of parents 
with high cholesterol levels as compared to parents of low cholesterol values, for both total 
cholesterol and low density lipoprotein cholesterol. The differences appear to remain fairly 
constant throughout childhood. This is further substantiated by the analysis of chauge of 
cholesterol levels during childhood within subjects. Low density lipoprotein-cholesterol and 
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high density lipoprotein-cholesterol were shown to track to a similar extent as their main 
constitnent apolipoproteins B and A-I, respectively (45). One might speculate that tracking 
by parental risk of these apolipoproteins resembles tracking by parental risk of their 
corresponding lipoproteins. For the angiographic patient-offspring stndy on apolipoproteins 
and coronary atherosclerosis as described in chapters 2 and 3 of tills thesis more direct 
information on tracking by parental risk was available. Studies on the relation between 
apolipoprotein levels in offspring and myocardial infarction in their parents indicated tracking 
by parental risk of apolipoprotein levels (42-44). There have been no studies on tracking by 
parental risk of postprandial lipoproteins. Tracking of postprandial lipid response to an oral 
lipid load may be related to the tracking of determinants of this response such as triglyceride 
level and high density lipoprotein, (37). However, inference about tracking of this response 
by parental risk is speculative. 
Summary 
In this chapter the familial aggregation of cardiovascular disease and of cardiovascular risk 
factors were discussed. Familial aggregation of cardiovascular risk factors within fanlilies and 
tracking of such factors by parental risk are the main premises for a patient-offspring study. 
Current evidence shows that lipids and lipoproteins are fanlilial, and that they as well as 
apolipoproteins show tracking. In previous stndies, tracking by parental risk was demonstrated 
for apolipoproteins in offspring of parents with myocardial infarction. For the studies in 
chapter 2 and 3 of this thesis the premise of tracking by parental risk was thus met for 
apolipoproteins but speculative for postprandial lipoproteins. 
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CHAPTER 7 
SUMMARY 
7. Summary 
Cardiovascular disease is the leading cause of morbidity and mortality in western 
industrialized countries. Nunlerous studies have shown that classical risk factors such as 
hypertension, high levels of total and low density lipoprotein·cholesterol, low high density 
lipoprotein·cholesterol and smoking are related to the occurrence of cardiovascular disease. 
The atherosclerotic process starts early in life and from an etiologic and a preventive point 
of view it is important to kuow if and to what extent this process and the diseases resulting 
from it are related to risk factors measured in the young. Cardiovascular disease aggregates 
in families, which implies that healthy relatives of patients with cardiovascular disease have 
an increased risk for developing the disease themselves. Current evidence suggests that if in 
certain families patient(s) have cardiovascular disease, otherwize healthy relatives of those 
patients have an increased risk of the disease, a relation which is seemingly not predominantly 
caused by aggregation of classical cardiovascular risk factors. Risk factors for cardiovascular 
disease are also kuown to aggregate in families, meaning that there is a resemblance of the 
levels of cardiovascular risk factors among fanlily members. A method for assessing the 
relation between putative risk factors and cardiovascular disease is to study such factors in 
offspring of patients with the disease. The general research question is if this new 
cardiovascular risk factor is causally related to the occurrence of the disease in the parents. 
Chapter 2 describes a study on postprandial triglyceride metabolism in 80 sons of fathers 
with angiographically established coronary sclerosis and in 55 sons of fathers who had at most 
only minor coronary atherosclerotic lesions at coronary angiography. Both groups of sons 
received an oral lipid load and the subsequent postprandial handling of this lipid load was 
studied in their serum for 12 hours after lipid loading. The sons of coronary artery disease 
patients had a prolonged postprandial hypertriglyceridemia. 
Chapter 3 describes a study on lipoprotein·cholesterollevels and apolipoprotein levels in 188 
offspring of fathers with angiographically established severe coronary sclerosis and in 115 
offspring of fathers who had at most only minor coronary lesions at coronary angiography. 
In this study sons of patients with coronary artery disease had significantly lower mean levels 
of high density lipoprotein3-cholesterol and of apolipoprotein A2. Although similar trends for 
high density lipoprotein3-cholesterol and apolipoprotein A2 levels were observed in daughters 
of patients none of the differences was statistically significant. 
Chapter 4 describes an 18-year follow-up study on cardiovascular risk factors in 252 male 
and 231 female children and young adults. These subjects were a random sample of 
youngsters initially examined in the cross-sectional EPOZ study, a population based study on 
risk factors for chronic diseases, conducted in 1975 - 1978 in the Dutch town of Zoetermeer, 
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and who were subsequently invited to take part in the follow-up study. In the initial EPOZ 
study, the parents of these subjects were also examined. Total cholesterol levels measured in 
the parents were then related to levels and change of levels of total cholesterol and its 
lipoprotein-subfractions, which were repeatedly measured on a yearly basis. The results show 
a strong cross-sectional as well as longitudinal relationship between parental total cholesterol 
levels and levels of total cholesterol and low density lipoprotein-cholesterol throughout 
childhood and adolescence. Overall, levels showed an initial tendency to decrease untill about 
15 years of age with a rise in levels thereafter. Despite these changes in lipid levels 
differences between groups of offspring contrasted by total cholesterol levels in their parents 
appeared to be stable, indicating that parental total cholesterol level is not a major determinant 
of change of cholesterol and lipoprotein-cholesterol levels during childhood and adolescence. 
No offspring group differences were found for high density lipoprotein-cholesterol and its 
subfractions. 
In chapter 5 some considerations are given for the use of the patient-offspring study (chapter 
2 and chapter 3) as a means to study the putative causal relationship between some factor as 
measured in offspring, and disease as measured in parents. It is postulated that familial 
aggregation of the risk factor as well as tracking by parental risk of the factor in offspring are 
premises for the patient-offspring study. An often used approach to the patient-offspring study 
is the offspring-perspective which means that offspring of parents with cardiovascular disease 
are at increased risk for the disease and risk factors measured in offspring are related to their 
increased disease risk. It is shown in chapter 5 that familial aggregation of disease is not 
sufficient as a premise for the patient-offspring study. The parent-perspective to the patient-
offspring study considers risk factor levels in offspring as an approximation of the level of 
the factor in parents when they were of the age of their offspring. Thus, consideration of the 
premise of familial aggregation of the risk factor is a logical step in this perspective and, 
therefore, the parent-perspective is postulated to be a preferable approach to the patient-
offspring study. 
In chapter 6, the patient-offspring studies as described in chapters 2 and 3 are discussed in 
the context of the current evidence for the relation between cardiovascular risk factors and 
familial aggregation of cardiovascular disease. The study as described in chapter 4 is discussed 
as being further evidence for familial aggregation of cardiovascular risk factors such as total 
cholesterol and low density lipoprotein-cholesterol and as a model to investigate the premises 
for the patient-offspring study. 
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Hart- en vaatziekten vormen de belangrijkste oorzaak van morbiditeit en mortaliteit in 
westerse geindustrialiseerde landen. Vele studies hebben aangetoond dat klassieke 
risieofaetoren zoals hypertensie, verhoogde plasma gehalten van totaal en low density 
Iipoproteine-eholesterol en roken zijn gerelateerd aan het ontstaan van hart- en vaatziekten. 
Het proees van atheroselerose begint vroeg in het leven. Het is daarom van belang vanuit 
etiologiseh en preventief oogpunt om na te gaan in hoeverre dit proees en de daaruit 
resulterende ziekten samenhangen met risieofaetoren bij jongeren. Hart- en vaatziekten 
aggregeren in fanlilies, hetgeen suggereert dat gezonde verwanten van patienten met hart- en 
vaatziekten zelf een verhoogd risico hebben op deze ziekten. Ook risicofaetoren voor hart- en 
vaatziekten aggregeren in fanlilies, betgeen betekent dat niveau's van deze risieofaetoren in 
met elkaar verwante familieleden overeenkomen. Onderzoek laat zien dat gezonde verwanten 
van patienten een verhoogd risieo op hart- en vaatziekten hebben, waarbij kan worden 
aangetekend dat deze relatie niet uitsluitend kan worden verklaard op basis van familiaire 
aggregatie van cardiovasculaire risicofactoren. 
Een methode om de relatie tussen veronderstelde risieofaetoren en hart- en vaatziekten te 
onderzoeken is het bepalen van zulke risieofactoren in nakomelingen Van patienten die Iijden 
aan dergelijke ziekten. De algemene onderzoeksvraag is daarbij of er een causaal verband 
bestaat tussen deze risieofaetoren en het ontstaan van de ziekten. 
Hoofdstuk 2 beschrijft een onderzoek naar het postprandiale triglyeeriden metabolisme in 
80 zonen van vaders met angiografisch aangetoonde coronair atherosclerose en in 55 zonen 
van vaders die bij angiografie hoogstens minimale eoronairafwijkingen hadden. Beide groepen 
zonen kregen een orale vetbelasting toegediend en de postprandiale verwerking daarvan werd 
bestudeerd in het bloed gedurende 12 uur na toediening van de vetbelasting. Zonen van vaders 
met corooair atherosclerose hadden ten opzichte van zonen uit de controle groep een verlengde 
postprandiale hypertriglyceridaemie. 
Hoofdstuk 3 beschrijft een onderzoek naar niveau's van Iipoproteine-cholesterol en 
apoproteinen in 188 nakomelingen van vaders met angiografisch aangetoonde eoronair 
atheroselerose en in 115 nakomelingen van vaders met angiografisch hoogstens minimale 
eoronaire afwijkingen. Zonen van patienten hadden gemiddeld statistisch significant lagere 
waarden van high density Iipoproteine3-eholesterol en van apoproteine A2. Hoewel 
vergelijkbare trends voor waarden van high density Iipoproteine3-eholesterol en apoproteine 
A2 te zien waren bij doehters van patienten waren de groepsverschillen niet statistiseh 
significant. 
Hoofdstuk 4 beschrijft een vervolgstudie, uitgevoerd over een periode van 18 jaar, naar 
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cardiovasculaire risicofactoren in 252 mannelijke en 231 vrouwelijke kinderen en jonge 
volwassenen. Deze groep kinderen vormde een random sample uit jongeren die zijn 
onderzocht in het Epidemiologisch Preventief Onderzoek Zoetermeer (EPOZ). Het EPOZ 
onderzoek is een populatie onderzoek naar risicofactoren voor chronische ziekten, dat in de 
periode 1975 - 1978 is uitgevoerd in Zoetermeer. Deze groep heeft deelgenomen aan een 
vervolgstudie waarbij serom totaal cholesterol gehalten en lipoproteinen-fracties jaarlijks zijn 
gemeten. In het EPOZ populatie onderzoek zijn serom totaal cholesterol gehalten tevens 
eenmalig gemeten bij de ouders van deze groep kinderen. De gehalten in de ouders zijn 
bestudeerd in relatie tot de herhaald gemeten gehalten bij hun kinderen. De resultaten laten 
zien dat er een sterk cross-sectioneel en ook longitudinaal verband bestaat tussen ouderlijke 
totaal cholesterol gehalten en de totaal cholesterol en low density lipoproteine-cholesterol 
gehalten bij kinderen en jonge volwassenen. In aHe groepen kinderen vertoonden de totaal 
cholesterol gehalten een daling tot ongeveer het 15e jaar en daarna een stijging. Ondanks deze 
veranderingen bleven de verschillen tussen de groepen kinderen, ingedeeld naar cholesterol 
niveau's van hun ouders, gelijk. Dit wijst erop dat ouderlijke cholesterol gehalten weI een 
belangrijke determinant zijn van de niveau's van totaal cholesterol en low density 
lipoproteine-cholesterol tijdens de jeugd, maar niet van de veranderingen hierin in de tijd. 
Voor high density lipoproteine-cholesterol en de subfracties daarvan werden geen verschiHen 
bij de kinderen waargenomen. 
In hoofdstuk 5 worden eakele overwegingen gegeven voor het onderzoeken van patienten 
en nakomelingen (patient-offspring onderzoek, hoofdstukken 2 en 3) als methode om het 
veronderstelde oorzakelijk verband te bestuderen tussen een risicofactor zoals gemeten in 
kinderen en de ziekte zoals gemeten in hun ouders. Besproken wordt dat familie aggregatie 
van een risicofactor alsmede "tracking naar ouderlijk risico" van de risicofactor in de kinderen 
aannamen zijn voor de patient-offspring studie. Een vaak toegepaste benadering van de 
patient-offspring studie is de benadering vanuit de kinderen (offspring-perspective). Dit houdt 
in dat kinderen van patienten met cardiovasculaire ziekten zelf een verhoogd fisico op deze 
ziekten hebben en risicofactoren, gemeten in de kinderen, worden gerelateerd aan dit 
verhoogde ziekte risico. In hoofdstuk 5 wordt gedemonstreerd dat familie aggregatie van 
ziekte als aanname niet voldoende is voor de patient-offspring studie. Bij de benadering vanuit 
de ouders (parent-perspective) worden niveau's van risicofactoren in kinderen beschouwd als 
een schatting van de .niveau's van deze factoren in de ouders toen zij de leeftijd van hun 
kinderen hadden. In deze benadering is het een logische stap om rekening te houden met de 
aanname van familie aggregatie van de risicofactor. Om deze reden zou in de patient-offspring 
studie de benadering vanuit de ouders moeten worden verkozen boven die vanuit de kinderen. 
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In hoofdstuk 6 worden de patient-offspring studies zoals beschreven in de hoofdstukken 2 
en 3 geplaatst in het licht van de huidige kennis over de relatie tussen risicofactoren en 
familie aggregatie van hart- en vaatziekten. Het in hoofdstuk 4 beschreven onderzoek wordt 
besproken als nieuwe aanwijzing voor familie aggregatie van risicofactoren voor hart- en 
vaatziekten zoals totaal cholesterol en low density lipoproteine-cholesterol geh.lten. Tevens 
wordt dit onderzoek beschreven als model om de aannamen voor de patient-offspring studie 
te onderzoeken. 
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